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Kleine, Gangan 
and my parents
And so, reluctantly, I have been driven 
back to my starting point, like a man 
who at the end of a long journey is told 
that he has been sleepwalking. "Truth1’ 
said Balthazar to me once, blowing his 
nose on an old tennis sock, "Truth is 
what most contradicts itself in time"
Lawrence Durrell
SUMMARY
The published work on the behaviour of trichiorofluoromethane in 
biological systems is discussed and compared with carbon tetrachloride 
and halothane.
The possible metabolism of trichiorofluoromethane by liver microsomal 
preparations in vitro under aerobic and anaerobic conditions has been 
investigated. Evidence is presented which suggests that metabolism 
occurs under both of these conditions. The rate of oxidative metabolism 
was found to be similar to that of carbon tetrachloride. In anaerobic 
microsomal preparations fortified with NADPH trichlorofluoromethane 
exhibited a Soret maximum at h ^ 2 nm in the difference spectrum.
Experiments in whichL CJtrichlorofluoromethane was dosed orally to 
rats support the findings iri vitro and show the formation of metabolites 
in the expired air and urine. The major metabolite was carbon dioxide.
I k C~labelled metabolites of trichlorofluoromethane were found to bind 
irreversibly to liver microsomal proteins and lipids in_ vitio. The 
possibility of similar reactions occurring in vivo is discussed.
Evidence is presented which indicates the involvement of the hepatic 
microsomal mixed function oxidase system in the metabolism of 
trichlorofluoromethane. In this respect trichlorofluoromethane is 
very similar to carbon tetrachloride but is not hepatotoxic. This 
phenomenon is discussed in relation to the possible mechanisms of 
halogenated hydrocarbon hepatotoxicity.
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CHAPTER 1.
INTRODUCTION
1Contents
1.1. General Introduction.
1.20 Toxicity of trichlorofluoromethane.
1.3. In vivo metaholism of the halogenoalkanes. 
l.k. Biochemical aspects of drug metabolism.
1.5. Present theories on the site of halogenoalkane activation and the 
mechanism of halogenoalkane toxicity.
1.6. Comparison of the properties of trichlorofluoromethane and carbon 
tetrachloride.
1.7. Introduction to present work.
1.1. General Introduction
The short chain halogenated alkanes have a large variety of uses.
These vary from industrial solvents e.g. carbon tetrachloride and 
trichloroethylene, to anaesthetic gases e.g. 2-bromo-2-chloro-l,l,l-tri- 
fluoroethane (t^alothane). A major use of these compounds predominantly 
those containing fluorine and chlorine is in aerosol sprays. The high 
volatility of the chlorofluoroalkanes and their apparent low toxicity 
made them ideal for use as pressure stabilizers and aerosol propellant 
gases. Trichlorofluoromethane (CCl^F) and dichlorodifluoromethane 
(CCl^F^) are the compounds most used for this purpose. The estimated 
world production of CCl^F and CCl^F^ in 1973 was ^73 x 10^ and 570 x 10^ 
tons respectively (as McConnell et al., 1975)* A variety of products 
are prepared as aerosol sprays, these vary from therapeutic preparations, 
for example in the administration of sympathomimetic amines and steroids 
in the treatment of asthma, where the preparation is inhaled directly into the 
lungs, to general household preparations, such as hair lacquers, deodorants 
and fly sprays where human contact is incidental.
The anaesthetic properties of the halogenoalkanes hawe.been known 
for 130 years. Chloroform was the first of these compounds to be 
introduced for this purpose and carbon tetrachloride was also used for 
a short period. However both of these compounds were found to be toxic, 
especially to the liver, and are no longer used as anaesthetics.
Halothane was introduced as an anaesthetic gas in 1956 and was initially 
thought to be non-toxic and metabolically inert, and for these reasons 
was thought to be an ideal anaesthetic gas . However in the last 10 - 15 
years a great deal of controversy has arisen as to the safety of this 
anaesthetic. The literature published on this theme is voluminous
(For reviews see National Halothane Study, 1966; Carney & Van Dyke,
1972; Grimineisen, 1973; Conn, 197^)«
1.2. Toxicity of trichlorofluoromethane
Human exposure to the halogeno alkanes results from deliberate, 
accidental or incidental inhalation. For this reason the majority of 
experiments on the toxicity of these compounds has been to determine the 
effects of an inhaled dose in humans and in laboratory animals. The 
work in this thesis is predominantly concerned with the compound 
trichlorofluoromethane, and the literature on the toxicity of the 
h a l o g e n o  alkanes is discussed with relevance to the potential toxicity 
of this compound. Literature on the toxicity of CCl^F and other 
chlorofluoroalkanes has been reviewed by Clayton (1962; 1966; 1967a and 
1967k) and comprehensively up to 1972 by Cox (1972). The relevant 
investigations into CCl^F toxicity will be mentioned briefly here.
Clayton (1967a; 1967b) refers to a report by the Underwriters 
Laboratories in which 12 guinea pigs were exposed for periods up to 
2 hours to 20% v/v CCl^F. Examination of vital organs after this period 
showed no evidence of any toxicity. In contrast a parallel series 
of experiments using CCl^ showed that inhalation of 2% v/v for 2 hours 
proved fatal. Nuckolls (1933) showed that exposure of guinea pigs 
to an atmosphere of 5% v/v CCl^F for two hours produced loss of 
coordination. After 2 hours at a concentration of 10% v/v, anaesthesia 
and convulsions were observed. CCl^F^ also behaved similarly but 
required concentrations of 30% v/v before the effects became manifest. 
Lester . & Greenberg (1950) also investigated the inhalation toxicity 
of CCl^F and various other halogeno-hydrocarbons. These workers showed 
that an inhaled dose of 8% v/v CCl^F in rats resulted in deep anaesthesia
as measured by loss of corneal reflex. Administration of 1 0 % v/v 
CCl^F for 20 - 30 minutes resulted in animal death, probably from 
respiratory failure. No evidence that CCl^F had caused liver 
damage could be found. These findings were in agreement with those 
of Scholz (1962), who reported acute and chronic toxicity studies 
using CCl^F in rats, guinea pigs, cats, and dogs. Inhalation of 
10# v/v CCl^F by rats and guinea pigs proved fatal after a short 
period of time, but Scholz could find no evidence that CCl^F had 
caused any disturbances in respiration, cardiac activity or blood 
circulation. A report by Slater (1965) showed that after CCl^F 
administration to rats no changes in liver NADPH levels or in serum 
enzyme levels could be observed. Kubler (.1963) and Guillerm et al,
(i960) have both reported that the inhalation of CCl^F does not effect 
lung histology or lung function. However there is a report by Quevauviller 
et al. (1963) that after inhalation of 1% v/v CCl^F by mice for 2k h!^ , 
some histological changes in the lungs were observed.
Long term toxicity experiments have been reported by Clayton 
(1966), Jenkins et_ al.(1970), and Scholz (1962). The results of these 
experiments are summarised in Table 1.1. Table 1.1, illustrates that 
even after long term inhalation of CCl^F there are no obvious signs of hepat 
toxicity. In this respect CCl^F is therefore essentially non-toxic.
The report by Bass (1970) that 110 American youths had died 
suddenly as a result of direct inhalation of aerosol propellant gases 
was explained as being probably due to severe cardiac arrhythmia. This 
was the first report to• indicate that the aerosol propellants may 
be toxic to the heart and initiated a great deal of research into this 
phenomena, especially in view of the fact that some medical preparations 
also involved the direct inhalation of aerosol propellants. Work by
Ta
bl
e 
1
.
1
. 
Su
mm
ar
y 
of 
th
e 
li
te
ra
tu
re
 
on 
th
e 
lo
ng
 
te
rm
 
to
xi
ci
ty
 
of 
CC
l^
F 
•
n
0 0
P rH
O0 d
1—1 0
cd cd
d >
0
d 1—1
>3 3 cd
bO 0 0
O ft • H
rH
O d"
P •H d
P cd d
cd d 0ft ft d
•
ts  0 1—1
bo cd
>> d a
f t  cd d
0 p O
f t  0 ft
0
ao
•H
-P
cdt>
d
0
0
PO
>3
p•H
■d
-p
do
g
* ^« O P
cd -h
a  -p
0  cd 0 i—|
>» 2 P  3  
ft 0
cd H  >
P
d
-P  cd
bD P  
•H  -P  
r—I ft  
CD 0  
P
d  d  
O *H •H
-p 0
cd 0 
d  cd 
•H 0 
f t  d  
0 0 
0  d  « -H
ft"
o
ft« CJ
d  3O D1 
•H
+ 3  ft
O bO
a d•H
b o p  
d  o
•rj P
0 > 
P  -P O
P  
•« P
0  bO ft -H
Cd r-1 
d  CD
0
d
bD >»
*H d
0 cd
p  d
d  *h
cd
0
•H P
ft  -H
•H O
d d  -H 0
0 bD X  0
> •H O *rl
0 0  P  O
0 0
0 O ft ft
d ft  O 0
f t
X
0 g
CD
P 0
d f t
•H cd
f t f t
g
d
0 +  0
>3 s>
cd O H O
ft H r —1 0  
0
d
>3
cd
P
P ft -
* O
d  0 O
0  a O
d  ft **
0  f t CM
0 — H
Po
i—I o
cd p  o
•H 0 
bO H  O ft 
i—I cd
° ■£ P  2  
0  ftH ft 
f t  d  00 
P  H  
O P  O
f t  cd o
H 0 i—I (H 0 
cd cd *H
a  CJ
d  d  0  O O ft 
^ ft 0
VO VO f t -  f t  CM H  
O O O O O O
g  f t  g  f t  g  a
0 0 
td  Idft ft
CO LA 
CM H
0 p  
bD-H 
0 0 «H ft 
O O ftp 
•H  *H  I cd 
g  g  o  ft
>5ft
0l>o
CJ
0u
VO
ooon
d  P
cd d
0 cd
P
r\ •
d  g 0
•H 0 i>
d 0
0  P f t
0  *H cd
bD f t
d 0
cd *> cd
P  d
0  0 0
t> S
O • H CO
ft H CD
H  0 0
1—1 1—1 0 cd
cd cd -H 0
a  0 0t>
d  d  0 a o
O O f t ccft
f t  f t  0 CDcd
>3
P
•HO
•H
xo
p
fto
o
ft
CM 00 LA
c~ g
0
bD
0 -H 0 
f t  f t - P  
cd I cd 
o  O  ft
>3
P
•H
O
•Hxo
p
fto
o
ft
CM
O
CM
0
bO
O
ft
0
>3 VO
O O cd f t
CM CM P  0 d
0 O
LA £ f t
0
P  1 d
d  p 0
LA LA cd d d
• • 0 d
00 00 CO CJ •H
O 0 0 CO
O 0 LA O
O LA CM O
n #1 •> p n
LA CM 0  d H
CM 1—1 H  cd
CM
O • H 0 0
•H P ft 3 0 •
P d •H H cd 0 p
cd cd O 0 bD 0
d 0 ft d O 0
d 0 ft 0 0 P H
0 p 0 d P
H cd 1 d H d
O d d 0 •H d
0 0 •rH •H
0 d ft P • d
•rH •H cd 0 0 0
P rt 0 bD 0
d • CO •rH O bO
P 0 to H 0 d d
H t> bO f t 0 P cd
. r-j •H •H d ft•H P
g H ft•rH 0 d 0
P
0
d
CJ
X
0
0ft•H
d
B
d
.3
0 0 
d  d  •H *H
H  0  
cd 
ft
O
£3 0
cd p  0
cd 
d
0
cd f t  
0
0 d  
0  cd 
cd d  
H ft ft
d  f t  
0  d  
>  ' 
•H  
rH
i•H
ft•H
d
bO•H
0
ft
o
0  . 
d  
bO •H 
0
ft
0
0  d  
bO cd 
d  f t  P  
cd a  P
f t  O -H  o o >
ft
d
cd g  
>  P
•H  O •H
o o 
f t  p
■so
CO C— CO b— CM CJ\ 
O O O O O H
CO t— CO C— CM O n
g  f t  g  f t  g  g
0 0 
P  P  
cd cd
0 0 P:
bO bD 0 
• H  *H  0 f t  
ft ft bO d1 I O O 
f t  f t  CD O  f t  g
0
ft
0
0
>
00 (l
) 
J&
ke
n 
fr
om
 
Cl
ay
to
n 
(1
96
6)
 
(2
) 
Ta
ke
n 
fr
om
 
Sc
ho
lt
z 
(1
96
2) 
(3
) 
Ta
ke
n 
fr
om
 
Je
nk
in
s 
et 
a
l
. 
(1
97
0)
Taylor & Harris (1970) on the effects of aerosol propellant gases 
on cardiac function in mice confirmed the proposal by Bass that these 
compounds could cause cardiac ar]Jythmia, the effect was most marked 
when the animals were partially asphyxiated. These authors also 
suggested that other forms of cardiotoxicity may occur for example 
ventricular irritability or myocardial or vascular depression. The 
similarity between the nature of the arijythmia and that reported for 
the similar compound halothane by Goldberg (1968), and the fact that 
halothane is known to depress myocardial contractility supported this 
possibility. Reinhardt et al. (1971) reported that CCl^F sensitises 
the heart to adrenaline and suggested that this was a possible mechanism 
of the CCl^F induced cardiac ariVthmia. Asthma sprays contain 
corticosteroids, and it was suggested that the increased mortality 
in patients using bronchodilator sprays was attributable to cardiac 
arx^rthmia induced by the inhalation of the propellant gases. However 
a paper by Harris (1971) suggests that this is not the case. A great 
deal of work has been carried out on the effects of aerosol propellants 
on the function of the cardiac and respiratory systems by Aviado 
and co workers (for reviews see Aviado, 197^ -; Aviado, 1975a; Be3ej & 
Aviado, 1975; Aviado & Drimal, 1975). Aviado and co workers 
investigated 15 aerosol propellant gases and found CCl^F to be the most 
toxic .(Aviado, 1975h). Table 1.2. is a summary of work by Aviado and 
co-workers showing the effects observed in various animal species on 
CCl^F inhalation, and the minimum inhaled dose required to produce these 
effects.
Two causes of death attributable to CCl^F have therefore been 
proposed; respiratory failure (Lester & Greenberg, 1950) and cardiac 
toxicity (Bass, 1970; Taylor & Harris, 1970). Both of these phenomena 
require relatively high doses of CCl^F.
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There are no reports in the literature that CCl^F induces 
any liver toxicity, however this possibility cannot totally be ruled 
out. In view of the reported hepato-toxicity of many halogenoalkanes 
it is to be expected that if CCl^F is at all toxic it would exhibit 
similar effects to those already reported for analogous halogenoalkanes. 
Three distinguishable forms of hepatotoxicity induced by these com­
pounds. have been reported in the literature:- l) Necrosis of liver 
resulting directly from the administration of compounds like CCl^,
CHCl^, CCl^Br. 2) hepatocarcinogenicity e.g. CCl^ and 3) liver 
necrosis resulting from halothane administration with symptoms very 
similar to those exhibited by viral hepatitis.
Of the compounds which have been shown to cause direct liver 
necrosis CCl^Br is the most toxic, CCl^ being the next most toxic 
(Koch et al., 197*0* All these compounds appear to exhibit similar 
toxic effects and it has been suggested that their toxic action is the 
result of the formation of active metabolic intermediates (Wirtschafter 
& Cronyn, 196*+). The majority of work has been carried out on CCl^.
Initial reports on CCl^ toxicity in man were made many years ago 
and since then many workers have investigated this phenomenon in 
laboratory animals. Histological investigations have shown that a few 
hours after CCl^ administration the cells near the central vein appear 
swollen and after 2k hours a centrilobular necrosis appears 
(Cameron & Karunaratne, 1936; Wigglesworth, 196*f). Schotz & Recknagel 
(i960) reported that soon after an oral dose of 1 ml/kg CCl^ a large 
accumulation of fat occurs in the liver.
Other phenomena associated with CCl^ toxicity are; leakage of liver 
enzymes into the blood e*g. increased SGPT levels (Magos & Bbtler, 
1975)^ decrease in liver glucose-6-phosphatase activity (Reynolds & Yee 
1968; Heni & Remmer, 1971), and destruction of liver cytochrome P-U50 .
(Dingell & Heimberg, 1968; Sasame et al, 1968; Slater & Sawyer, 1969;
Davis et_ al, 1971; Vorne & Arvela, 1971; and Barone et al., 1973). There
is also evidence that CCl^ administration increases the in vivo rate of
lipid peroxidation in the liver (Klaasen & Plaa, 1969; Recknagel et_ al.
✓ ' '
197^).
Another phenomenon reported to result from CCl^ administration is 
the detachment of ribosomes from the rough endoplasmic reticulum 
(Smuckler & Benditte, 1963; Smuckler & Benditte, 1965).
Williams & Rabin (1971) have reported that this phenomenon can 
be observed and quantitated in microsomal preparations in vitro 
and is exhibited by a large number of hepatocarcinogens. Carbon 
tetrachloride has been shown to be a hepatocarcinogen when administered 
to mice (Andervont & Dunn>1955; Andervont, 1958; Edwars, 19UI;
Edwars & Dalton, 19*+2; Edwars et al,, I9U2), and also when dosed to rats, 
(Reuber, 1970; Reuber & Glover, 1970).
It is not clear§whether the liver tumours result from the direct 
action of CCl^ or whether they occur as a result of the chronic 
liver damage which occurs after CCl^ administration. CCl^ is the only 
short chain halogenoalkane reported to be hepatocarcinogenic.
The controversy over the use of the anaesthetic gas halothane 
arose after a number of reports of chronic hepatitis in patients after 
halothane anaesthesia (Burnap et al5» 1958; Lindenbaum & Leifer, 1963; 
Blackburn et al., 196*1-). This phenomenon only appeared to occur after 
the second administration of the anaesthetic, which in some cases 
was a period of weeks or even months after the first dose. The 
hepatitis observed was similar to viral hepatitis although some differences 
were observ^able (Klion et al, 1969; Peters et al, 1969)* 30 - 50 % of all 
patients contracting this disease have died. There have also been
many reports of liver damage in anaesthetists and people working 
in close contact with halothane (for a review see Grimmeisen, 1973).
In view of the nature of this phenomenon it was proposed that 
toxicity was the result of a sensitisation reaction which is initiated 
on administration of the first dose. This distinguishes this type of 
hepatotoxicity from the direct hepatotoxic action of compounds like 
CCl^. Halothane has been shown to be metabolised in the liver 
endoplasmic reticulum (Van Dyke et al., 196*+a; Van Dyke & Chenoweth, 
1965)9 and halothane metabolites have been shown to bind covalently 
to liver macromolecules particularly proteins (Uehleke et al, 1973b; 
Van Dyke & Gandolfi, 197*+)* It has been proposed that a halothane 
metabolite bound to hepatic protein may act as the antigen which 
initiates the sensitisation reaction.
There is some evidence that halothane may also cause direct 
hepato-toxicity in the liver, e.g. the accumulation of liver lipid 
(Jones et_ alo9 1958; Stephen et al., (1958), and an increase in 
serum SGPT and SGOT levels has been reported by Zimmermann et_ alQ 
0-971). Stevens et_ al. (1975) showed that a dose of halothane induced 
liver necrosis in rats and guinea pigs.
The published experiments on the toxicity of CCl^F have been 
mainly concerned with the inhalation toxicity, the only report on 
the effects of an injected dose is by Cox (1972). No changes in 
the lipid content in the livers of rats dosed 2.5 g/kg CCl^F for 
5 days or in rats receiving *f00 mg/kg for 37 days and no signs of 
liver toxicity were detected in either case.
In aerosol preparations CCl^F is always applied in conjunction 
with other compounds. Epstein t^_ al. (1967a; 1967b) showed that when 
CCl^F is dosed in conjunction with the insecticide synergist piperonyl
butoxide, there is an increased incidence of liver tumours in 
male rats. In view of these findings it is surprising that work 
in this area has been so limited.
1.3. In vivo metabolism of halogenoalkanes
When halogenoalkanes are administered to humans or to laboratory 
animals a large proportion of the dose is exhaled unchanged. A small 
proportion of the dose has been shown to be metabolised to CO^ and to 
non-volatile metabolites in the urine and faeces. McCollister 
et al. (l95l) reported that after an inhaled dose of carbon tetrachloride 
(*+6 ppm for 300 min), 11$ of the dose was metabolised to CO2 after 
1800 h and that about 30$ of the dose had been metabolised to non­
volatile compounds excreted in the urine. 10.2 $ of the metabolites 
in the urine was urea and 1.3$ was carbonate; other metabolites in 
the urine were not identified.Butler (1961) reported that a small 
proportion of an inhaled dose of CCl^ to dogs was exhaled as chloroform. 
Paul & Rubinstein (1963) reported that 18 h after an oral dose of 
CCl^ (1.5 g/kg body weight) to rats^ 1.0$ of the dose was metabolised 
to CO^ and a small proportion to CHCl^. Similar results were reported 
by Seawright & McLean (1967) who reported that 2k h after an oral 
dose of 3.8 g CCl^/kg body weight to rats 0.*+$ was excreted as CO,-,. 
Fowler (1969) reported that 6 h after an oral dose of CCl^,
2.3 - k . 5 g/kg to rabbits trace amounts of chloroform and 
hexachloroethane wft*edetected in the liver, fat, kidney and muscle.
Bini et al. (1975) reported similar findings. Chloroform and 
hexachloroethane were detected in the livers of rats 15 min after 
an oral dose of between 0.75-3.75 g/kg.
12
Reynolds (1967), Reynolds & Yee (1967) and Reynolds &
Moslen (1974) showed that shortly after the administration of
radioactive CCl^ to rats, radioactive metabolites were found bound
covalently to protein and lipids. Similar findings have been reported
by Rao & Recknagel (1969). Gordis (1969) has reported the very
rapid incorporation of CCl^ metabolites into liver lipids. 0 * 5 %
of the administered dose was found to be bound, and the majority
of binding was associated with the phospholipid fraction. Covalent
binding of CCl^ to D M  in vivo has also been demonstrated by Rocchi
et_ al,(1973). Many investigations into the covalent binding of 
14 . . .
CCl^ metabolites to subcellular constituents m  vivo have been 
carried out by Castro & co-workers (DfAcosta et al^ 1972; D ’Acosta 
et akj 1973; Castro & Diaz Gomez, 1972; Castro et al., 1973a;
Castro et al»i1973b; Diaz Gomez et al., 1973; Villaruel & Castro, 1973).
Halothane was shown to be metabolised by Stier (1964a; 1964b) 
who reported the excretion of bromide in the urine of patients after 
halothane narcosis, and the excretion of trifluoroacetic acid 
in the urine of rabbits. Van Dyke et al. (1964a) reported the 
excretion of metabolites containing radioactive chloride after injection
' Halothane had previously been thought to be biochemically 
inert (Vandam 1963) but it has now been shown that up to 2 5% is 
metabolised (Rehder et_ al., 1967; Cascorbi et al.,1970). Van Dyke 
et al. (1964b) reported that 24 h after an injected dose of 
J C^^ j halothane to rats 1.56% of the dose was detected in the urine 
and 0.84$ was ^CO^. Further evidence for halothane metabolism is 
provided by Cohen (1969) who detected covalently bound halothane 
metabolites in the livers of mice after intravenous injection.
13
These findings have since been confirmed by Werner & Uehleke (197^) 
who detected metabolites bound to liver microsomal protein and lipids 
after i.p. injection of ( > ]  halothane in mice, and by Van Dyke & Gandolfi 
(197*0 "who reported similar findings in experiments using rats.
There are no reports on the 111 vivo metabolism of an oral dose
of CCl^F. Jenkins et al. (1970) were unable to detect any increase
in urinary excretion of fluoride ion in rats and guinea pigs after
1*+inhalation of CCl^F. After inhalation of CCl^F by dogs trace amounts
. . .  . . Ikof radioactivity could be detected m  the urine, as CO^j and as non­
volatile metabolites in the liver and other tissues (Blake & Mergner,
197*+). However, because of the presence of radio-labelled impurities
/lii it Ik
( 0C1^ and CHCl^) in their CCl^F sample these workers were not
able to rule out that the possibility that these metabolites were a 
result of the metabolism of these impurities. Investigations into the 
retention of CCl^F in humans have been reported by Dollery et al. (1970) 
and Paterson et al. (1971)9 and in dogs by Shargel & Koss (1972).
These workers all showed that maximum blood concentrations were obtained 
a few minutes after administration of the dose and then fell sharply.
There are many reports on the in vivo metabolism of halogenoalkanes 
other than CCl^ and halothane. The metabolism of CCl^ and halothane has 
been described here to give an indication of the nature of the metabolites 
normally obtained from such compounds, and in particular an indication of 
the metabolites that may be expected for the metabolism of CCl^F. The 
literature on the metabolism of other halogenoalkanes has been reviewed 
by Cox (1972).
1.4. Biochemical aspects of drug metabolism.
It is now recognised that most foreign compounds undergo metabolic 
changes before they are excreted in the urine, bile or exhaled air. The 
enzymes which are concerned with the metabolism of these compounds have 
been shown to be predominantly located in the liver endoplasmic 
reticulum (Brodie et al., 1955)5 although these enzymes have also been 
shown to occur in the kidneys, lungs, small intestine, placenta, adrenals, 
skin, and testes. This enzyme system is unique in the respect that it 
catalyses the oxidative or reductive metabolism of a wide variety of substrates 
of different chemical structure, for example the N oxidation of amines,
0, N, and S dealkylation, hydroxylation of alkyl and aryl hydrocarbons, 
e^poxidation, N and S hydroxylation, dehalogenation, and the reduction 
of azo and nitro compounds. Brodie et_ al. (1958) suggested that most of 
the oxidative reactions involved could be visualised as different types 
of hydroxylation reaction.
Foreign compounds are usually metabolised to more polar derivatives, 
so facilitating their excretion in the urine. The water solubility of 
these compounds in most cases is further increased by conjugation 
reactions . The common types of conjugation reaction, and the chemical 
nature of their substrates are shown in Table 1.3. A comprehensive review 
of conjugation reactions is presented by Mandel (1971)•
The metabolism of foreign compounds usually increases the rate of 
their excretion and in most cases foreign compound metabolism is a 
detoxication process. However there have been many reports that the 
metabolism of some compounds gives rise to more toxic metabolites 
(farke} 1968).
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The enzyme system responsible for the oxidative metabolism of
foreign compounds requires NADPH and oxygen, and has been termed a
mixed function oxidase system. The overall reaction for substrate
oxidation as proposed by Gillette (1963) is:-
NADPH + H
.+
+ 0^ + drug
+
-> NADP + H^O + oxidised drug
Two major proteins have been associated withthis enzyme system; 
a flavoprotein which appears to have very similar properties to NADPH 
cytochrome c reductase, and a carbon monoxide-Bensitive haem protein, 
cytochrome P-^50>reported by Klingenberg (1958) and Omura & Sato 
(l96^a)i Cytochrome P-^50 is a b type cytochrome, and when reduced 
with sodium dithionite in the presence of carbon monoxide exhibits 
a Soret maximum in the difference spectrum at ^50 nm. This cytochrome 
is believed to be the terminal electron acceptor in the electron 
transport chain, and the site of drug oxidation. Fig. 1.1„ is a
diagran^tic representation of the mixed function oxidase system.
The binding of substrate to the oxidised form of cytochrome P-^50 has 
been shown to change the iron atom from low spin to high spin 
(Waterman et al., 1973). An electron from NADPH cytochrome c reductase 
reduces the iron to the ferrous form (Orreniusj1965; Gigon et al., 1968; 
Masters et_ al., 1971) via an unknown intermediate. The reduced cytochrome 
P-l*50-substrate complex then binds a molecule of oxygen which is then 
reduced by a second electron to give an activated oxygen intermediate.
Two possible forms of this intermediate have been proposed, a superoxide 
anion and a hydroperoxide. One atom of oxygen is then transferred to the 
substrate and the complex dissociates resulting in the formation of oxidised 
substrate, water and low spin ferric cytochrome P-l+50. It has been 
suggested that the second electron can be donated by either NADPH or
NADH via a flavoprotein and cytochrome b but there is still a great
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deal of controversy concerning the roles of NADH and cytochrome
b,_ in mixed function oxidase-mediated reactions.
The interaction of substrates with the oxidised form of 
cytochrome P-l*50 produces two major types of spectra observable 
in the difference spectrum (Remrner et_ al., 1966; Imai & Sato 1966), 
These two types of spectral interaction have been termed type I 
and type II. Type I spectra are characterised by a spectral maximum 
between 385-390 nm and a minimum between l*l8-l*27»m-Type II spectra
have a X max between 1*25 ~ +^35 nm and X . between 390 - 1*05 nm.m m
350 1*00 
type I
_1
1+50 350 1*00
type II
T 50
A further type of spectrum has been observed which is the mirror
image of the type I spectrum and has been termed, "reverse type I"
or "modified type II". Remrner et al. (1969) determined the cause
of these spectra. The addition of type I substrates was found to
cause a shift in the X in the absolute spectrum of cytochromemax
P-l*50 to lower wavelengths. The addition of type II compounds
caused.a shift in the X to the higher wavelengths. When the differences
max
between the absolute spectra in the presence and absence of substrate 
were plotted curves identical to the characteristic binding spectra were 
obtained. A great many compounds are known to give a type I spectrum 
and it has been suggested that this spectrum represents the binding of 
substrate to the active site on the cytochrome P-l*50 molecule 
(Schenkman et al., 1967). The active site on the cytochrome P-l*50 
molecule and the type I site are thought to be in a phospholipid 
environment which is compatible with the fact that most substrates 
of cytochrome P“l*50 mediated metabolism are lipid soluble. The type 
II spectrum is in almost all cases produced by compounds containing 
primary amine groups (see Mannering, 1971)9 and is thought to represent 
the direct liganding of these compounds with the haem iron of the 
cytochrome P-l*50 molecule (Schenkman et al.,1967). The magnitude of 
the type I binding spectrum has been shown to be dependent on the 
concentration of substrate. Plotting the reciprocal of the 
substrate concentration against the reciprocal of the magnitude of the 
binding spectrum produces plots analagous to those reported by 
Lineweaver & Burk (193^) for enzyme-mediated reactions, for the 
determination of the Michaelis constant Km. Such analysis for the 
binding of substrate to cytochrome P-i*50 yields the spectral 
dissociation constant (Ks). Comparison of Ks and Km values for 
various drug substrates in most cases gives values of the same 
order of magnitude (Schenkman et al., 1967; Mannering^1971)»
Another type of spectral interaction, in which substrate 
interacts with reduced cytochrome P-l*50 has also been reported.
Such spectra are documented for relatively few compounds, and
are associated with the interaction of an active metabolic intermediate
with the haem iron of cytochrome P-i*50. The compounds which form
these complexes can be split into two major categories:
Compounds which produce difference absorption maxima at **27 and 
1*55 nm, when incubated with microsomes,in the presence of NADPH 
and oxygen for example methylenedioxyphenyl compounds, such as 
piperonyl butoxide and safrole (Philpot & Hodgson, 1971; Franklin,
1971) and the spectra produced by the halogenated alkanes 
e.g. CCl^ and halothane (Reiner & Uehleke, 1971; Ullrich & Schnabel, 
1973; Uehleke, et al., 1973a; Mansuy et al., 197*0 which produce
difference spectra with a A ^ x  "between **50 and *+80 nm. The halogenated 
alkanes form such spectra in microsomes reduced with sodium 
dithionite or with microsomal preparations under anaerobic conditions 
in the presence of NADPH. On incubation of methylene dioxyphenyl 
compounds with microsomes reduced with sodium dithionite no spectrum 
is produced. Unlike the spectra produced with oxidised cytochrome 
P-**50 which form immediately on substrate addition, these complexes 
form slowly with time. Lineweaver - Burk analysis of the initial 
rate of formation of these complexes allows the calculation of an 
"apparent" K value. The formation of complexes by the methylene— 
dioxyphenyl compounds has also been shown to occur in vivo (Philpot 
& Hodgson, 1972; Gray, 197*0 •
1.5* Present theories on the site of halogenoalkane activation 
and the mechanism of halogenoalkane toxicity
In vitro investigations have proved invaluable for the elucidation 
of the components of the mixed function oxidase electron transport 
chain, and insight into its mode of action. The halogenoalkanes 
also show very similar properties in vitro to those reported in vivo.
For example similar to the ease in vivo, in vitro experiments have 
shown that:
1) CCl^ is' metabolised''.to carbon dioxide (Seawright &
McLean , 1967; Paul & Rubinstein, 1963; Rubinstein & Kanic s, 196*0.
2) CCl^ is metabolised to CHCl^ (Butler, 1961; Paul &
Rubinstein, 1963).
3) CCl^ induces lipid peroxidation (Reekna^l 8s Ghoshal 
1965; Ghoshal 8c Recknagel, 1965; Slater, 1968 and others).
4) CCl^ causes the destruction of cytochrome P-450 and 
inhibits the metabolism of foreign compounds (Heni, 1971; Reiner et al.,
1972; Uehleke et al., 1973a).
5) CCl^ binds covalently to the lipids and proteins of subcellular 
constituents (Rocchi et al., 1973; Uehleke et al., 1973a).
6) CCl^ induce^ a loss of ribosomes from the endoplasmic 
reticulum (Williams 8c Rabin, 1971) •
7) Loss of glucose-6-phosphatase activity (Slater, 1972),
The toxicity of the halogenoalkanes occurs predominantly in the liver, and 
because the site of drug metabolism is^known to be in this organ it was 
suggested that the toxicity of these compounds was a result of their 
metabolism. Butler (I961) suggested that the hepatotoxicity of the 
halogenated alkanes could be a result of the homolytic cleavage of these 
compounds to give toxic free radical intermediates. Wirtschafter 
8c Cronyn (1964) also suggested that this was the most probable mechanism.
The data available on the mechanisms involved in the toxicity of CCl^
will be discussed here:-
) '
Ghoshal 8c Recknagel (1965); R ao Sc Recknagel (1968) suggested that free 
radicals produced on metabolism of CCl^ were the initiating step in CCl^ 
induced lipid peroxidation, and that lipid peroxidation was the cause
of C C l ^ - i n d u c e d  cell necrosis. This theory has also been supported by
Slater (1966a). The following reports support the formation of free 
radicals.
1) Fowler (1969)^ Uehleke et al. (1973a) and Bini et_ al.
(1975) reported the in vivo metabolism of CCl^ to hexachloroethane. 
This compound could easily be produced by the dimerisation of two CCl^* 
radical species.
2) Compounds capable of trapping free radicals have been 
shown to protect against CCl^ toxicity in vivd and against CCl^ 
induced lipid peroxidation in vitro, e.g. the antioxidants; a toco­
pherol, and N,N, diphenyl-p-phenylene diamine
(Gohsal & Recknagel,1965; Smuckler et al., 1967; Castro et al., 1968; 
Slater & Sawyer,, 1971c).
The compound promethazine, has also been shown to protect against CCl^ 
toxicity in vivo and in vitro by this mechanism (Slater, 1968; Slater 
& Sawyer, 1969). A review of the literature in this field is reported 
by Slater (1972).
3) In the lipophilic environment of the mixed function oxidase 
system, the probable site of CCl^ activation, homolytic cleavage
of the C-Cl bond would be more favoured than heterolytic cleavage to
CV
4) The formation of CC1* would interact readily with 
neighbouring macromolecules to form covalent bonds; such interactions 
have been shown to occur.
5) R ao & Recknagel (1969) found a direct relationship 
between the rapidity of CCl^-induced lipid peroxidation and the 
rate of covalent binding. The suggested mechanism of lipid 
peroxidation also involves free radicals.
H Ji H
- C = C - C - C  = C - | - C = C - ( J | - C  = C -
CC1
CHC1
v/
■ c - c - c  = c -  c -  c = c -  c -  c = c -
organic free radical 
C - C - C - C  = C -  C = C -  C -  C = C -
y
diene conjugation
c = c - c - c - c = c - c = cI
?
decomposition to 
yield two free radicals
c.yclisation 
and decomposition to 
give malondialdehyde
Taken from Rao & Recknagel (1969)
6) Some workers have reported electron spin resonance 
studies which indicated the presence of CCl^ free radicals 
(Calligaro et al. 1970; Slater, 1972) although many other workers have 
had no success. There is therefore a great deal of evidence that 
indicates that the toxic intermediate from CC1, is a free radical.
Many investigations have been carried out to determine the site 
of CCl^ metabolism. Rubinstein & Kanies (196*0 showed that the 
enzymes responsible for the formation of CO^ from CCl^ were located 
in the liver microsomal fraction. Work by McLean & McLean (1966)
24
showed that increasing the concentration of components of the hepatic 
mixed function oxidase system hy pretreatment of the animals with 
phenoharbitone or DDT increased the .in vivo toxicity of CCl^ in rats. 
These workers also found that on reducing the activity of this system 
by feeding rats a low protein diet the toxicity of CCl^ was reduced. 
Similar results on the effects of phenobarbitone are reported by Lai 
et al. (197O3I; Sasame et al. (1968); Tuchweber & Kovacs (,1971) *
Slater (1966b) showed that CCl^-induced lipid peroxidation occurred 
in the microsomal fraction and required NADPH and oxygen. These 
findings indicated that both CCl^ metabolism to CO^ and CCl^-induced 
lipid peroxidation were mediated by the hepatic mixed function oxidase 
system. Investigations into the active sites in the mixed function 
oxidase electron transport chain responsible for CCl^ activation have 
been mainly concerned with the effects of selective inhibitors on 
CCl^ metabolism and CCl^-induced effects such as lipid peroxidation.
Two sites have been proposed; these are, the flavoprotein,
NADPH cytochrome c reductase, and cytochrome P-l+50. The concentrations 
of both these components are known to be increased by phenobarbitone 
pretreatment of animals, and therefore either of these sites could 
explain the results of McLean & McLean (1966). Slater & Sawyer 
(1971b) investigated the action of various inhibitors on CCl^-induced 
lipid peroxidation. The inhibitors used and their site of action are 
shown below.
Drug
NADPH ^ NADPH cytochrome .c reductase— >SH— X^-j_— ^Binding Site P-U50
Drug
Products
PCMB SKF525A GO
PCMB-- p-chloromercuribenzoate
SKF 525A:- 3-diethylaminoethyl-3-3fdiphenyl-propyl acetate 
Taken from Slater (1971b)
None of the above inhibitors were found to have any effect on CCl^ T" 
induced lipid peroxidation. This and the finding that the introduction 
of an alternative substrate for NADPH cytochrome c reductase, cytochrome c, 
inhibited CCl^induced peroxidation suggested that the site of CCl^ 
activation was on the NADPH cytochrome c reductase molecule. Evidence 
that cytochrome P-t50 is the active site for CCl^ metabolism has been 
presented by Seawright & McLean (1967) who showed that the microsomal 
conversion of CCl^ to CO^ was inhibited by 0,1 M SKF 525A. SKF 325A is 
thought to compete for the active site on the cytochrome P-^50 molecule.
It has also been reported by Slater (1966b) and Smuckler & Hultin (1966) 
that SKF 525A partially protects against CCl^ toxicity. The in vivo 
effects of SKF 525A on CCl^ toxicity are difficult to interpret as it 
is not clear whether the reduction in toxicity is due to reduced blood 
concentrations of CCl^ when dosed after SKF 525A administration or 
whether SKF 525A competes for the active site (Marchand et al., 1970). 
Tuchweber & Kovacs (1971) reported that the in vivo administration 
of SKF 525A to rats had no protective effect on CCl^-induced toxicity. 
Cignoli & Castro (1971) reported that, contrary to the report of Slater & 
Sawyer (1971b), the addition of SKF 525A to in vitro incubations of 
rat liver microsomes caused a large inhibition of CCl^-induced lipid 
peroxidation; other inhibitors of drug metabolism showed similar 
effects. It is interesting to note that Diaz Gomez et al. (1973) from 
the same laboratory reported that SKF 525A increased the irreversible binding 
of CCl^ microsomal lipids and did not alter the extent of binding to 
proteins. D ’Acosta et al-* (1973) showed that on the in vivo administration 
of 3-amino-l,2,t,-triazole, an inhibitor of haem synthesis, a reduction 
in CCl^-induced lipid peroxidation and a reduction in the binding of 
CCl^ metabolites to lipids was recorded. 3-'Anino-l,2,^-triazole has 
been shown not to affect NADPH cytochrome c reductase or the phospholipid
26
environment of cytochrome P-l^O (Baron & Tephlyjl969) which 
further indicates the involvement of cytochrome P-l+50. Diaz Gomez 
jab al* (1973) also showed that the administration of metyrapone,
another potent inhibitor of drug metabolism reactions, to rats,
. . .  . it
significantly decreased the covalent binding of CCl^ to microsomal
lipids. This finding is supported by the work of Uehleke (1973) 
who has demonstrated that the covalent binding of CCl^ to rabbit 
liver microsomal proteins is significantly inhibited by metyrapone 
and carbon monoxide, Reiner et ad.** (1972) have reported that the 
anaerobic dechlorination of CCl^ to chloroform in rabbit liver microsomes 
is inhibited by carbon monoxide and metyrapone, yet is enhanced 
by SKF 525A. Conflicting reports in the literature make it difficult 
to state categorically whether the covalent binding of CCl^ to lipids 
illustrates the initial activation of CCl^-induced lipid peroxidation.
For example Uehleke (1973) reported inhibition of covalent binding by 
carbon monoxide yet Slater & Sawyer (1971b) reported no inhibition of lipid 
peroxidation by this compound. For similar reasons it is not possible 
to obtain a clear insight into the site of CCl^ activation from literature 
reports.
However evidence exists that CCl^ is activated in the hepatic
f
mixed function oxidase system and that the site of activation is either 
the flavoprotein, NADPH cytochrome c reductase or cytochrome P--H50, 
or both. If both sites are involved it remains to be demonstrated 
whether the active intermediates formed at these sites are the same 
and whether it is CCl^ metabolism at one of these sites in particular 
that gives rise to its toxic effects.
1.6. Comparison of the properties of CCl^ and CC1J?
A comparison of the physical properties of CCl^ and CCl^F is 
shown in Qhble l'.l*. In many respects the physical properties of
these, two compounds are very similar, the major difference being the
boiling points. The toxicities of these compounds has already 
been discussed and unlike CCl^, CCl^F is not hepatotoxic. There is 
a report in the literature by Slater & Sawyer (1971a) that CCl^F 
causes a slight increase in the level of lipid peroxidation in rat 
liver microsomes, however Cox et al. (1972b) were unable to confirm 
these findings. It was suggested by Slater (1965) that the difference 
in the toxicities of CCl^F and CCl^ was due to the increased stability 
of the C-Cl bond in the CCl^F molecule due to the presence of the 
fluorine atom. However,as Table 1.1 .indicates the increase in stability 
of this bond is small, and would not be expected to account for such a 
large difference in their toxicities, especially in view of the fact that
many mixed function oxidase substrates have much higher bond dissociation
energies e.g. b enzene 102.'Kcal/mole* cyclohexane and n-hexane - 9^ K cal/mole 
A second possibility that could account for the difference in toxicity 
between these two compounds is the difference in their boiling points.
CCl^F is a very volatile compound and literature reports indicate that 
after inhalation of oral dosing it is eliminated very rapidly from the 
body. It is therefore possible that CCl^F is not retained in 
the body long enough to produce a toxic effect. The major argument 
against this suggestion is that the toxicity of CCl^ is initiated within 
the first 5 minutes after CCl^ administration (Rao & Recknagel, 1968;
Rao & Recknagel, 1969, Uehleke et al*, 1973a). CCl^F has been detected 
in the livers of experimental animals shortly after oral application 
(Cox et_ al. 1972b) and therefore would be present long enough to
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initiate similar effects. Also relatively low doses of CCl^ 
have been shown to cause liver damage, for example Reynolds &
Yee (1967) showed that administration of 15 mg CCl^/100 g body weight 
decreased liver glucose-6-phosphatase activity, and Recknagel & 
.Ghoshal (1966) showed that a similar dose produced a doubling 
in liver triglycerides in rats within 6 hours. These findings 
indicate that the concentration of halogenoalkanes that reaches the 
liver cannot be the factor which accounts for the differences in 
their toxicities.
Apart from the similarities in the physical properties of CCl^F 
and CCl^ there are also similarities in their interactions with the 
hepatic mixed function oxidase system. Both CCl^ and CCl^F give rise 
to a type I binding spectrum (McLean,1967; Cox et al., 1972a) and 
both these compounds give Soret maxima in the difference spectrum in 
the region of ^50 nm with sodium dithionite-reduced cytochrome 
P-i+50. CCl^F gives a Soret maximum at ^52 nm (Cox et al., 1972a; 
Uehleke et al., 1973a) and CCl^ gives a maximum absorption at ^5^ nm 
(Reiner & Uehleke, 1971 )• Cox'et al. (1972a*) reported that in rat liver 
microsomes CCl^F gives a much larger maximum with reduced cytochrome 
P-l+50 than exhibited by CCl^.
Cox et. al. (1972a) investigated the effect of CCl^F on the in vitro 
metabolism of several mixed function oxidase substrates using rat liver 
microsomes. They found that the addition of CCl^F (l mM) had no 
inhibitory effect on the metabolism of the type 1 substrates, biphenyl, 
ethyl morphine, and p-nitroanisol*and in the case of aniline, a type 
II substrate, an enhancement in the rate of metabolism was recorded. 
However Uehleke et al. ,(l973a) using rabbit microsomes reported 
that 5 mM CCl^F inhibited the dealkylation of N-methyl aniline by 60$,
the hydroxylation of N-methylaniline by 50$ and the N oxidation
t
of b - chloroaniline by bQ%. There are many reports in the literature 
on the inhibition of drug metabolism reactions by CCl^ (Dingell & 
Heimberg/1968; Sasame et al., 1968; Barker et al., 1969; Lai et al., 
1970b; Vorne & Alavaikko, 1971; and Uehleke et al., 1973a). However 
it is not possible to say whether the inhibition measured is a result 
of the direct competition of CCl^ with mixed function oxidase substrates 
for the active site on the cytochrome P-L50 molecule, or whether it is 
a result of the CCl^-mediated destruction of cytochrome P-U50.
There are therefore several similarities between the properties 
of CCl^ and CCl^F, however a viable explanation to account for the 
difference in the toxicities of these two compounds remains to be 
resolved.
1.7. Introduction to present work
The work reported in this thesis is predominantly concerned 
with the compound trichlorofluoromethane. It is aimed to 
investigate possible metabolism of this compound in vivo and in vitro. 
At present there are no reports in the literature on this theme.
As the metabolism of the halogenoalkanes is thoughtto be the 
initiating step in their hepatotoxicity such investigations may give 
some insight into the potential toxicity of CCl^F.
It is also hoped that the work reported here will help to account 
for the differences in toxicity of CCl^F and CCl^ and clarify some 
aspects of the mechanism of halogenoalkane-induced hepatotoxicity.
Chapter 2
The interactions of trichlorofliioromethane with liver microsomal 
preparations under anaerobic conditions
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2.1. Introduction
In view of the reported biochemical stability of CCl^F both 
in vitro (Slater 1963) and in vivo (Jenkins et al.f1970)» the work 
reported in this chapter was designed to determine whether biological 
activation of CCl^F could be detected. In vitro incubation systems 
were considered the most suitable for this investigation. If CCl^F 
is activated metabolically in a manner analogous to CCl^ homolytic 
cleavage of the C-Cl bond would be expected (Wirtschafter & Cronyn, 
196^). Because oxidised products of CCl^F would be difficult to 
detect it was considered that the most favourable conditions for the 
determination of such an activation would be in the absence of 
oxygen.
The absorption maximum in the region of 1+50 nm observed in the 
difference Spectrum when halogenated hydrocarbons, for example 
halothane or CC1^3 were added to liver microsomes reduced with 
sodium dithionite (Cox/19T2; Uehleke et al-,1973b; Reiner-& Uehleke, 
197l)j is thought to represent the formation of a complex between 
cytochrome P-l+50 and an active intermediate (Ullrich & Schnabel 
1973; Mansuy et_ al-,197^)« Reiner & Uehleke (1971) reported that under 
anaerobic conditions CCl^ exhibited an identical spectrum using 
NADPH instead of sodium dithionite. In this case the intermediates 
involved resulted from the biological activation of these compounds 
in the NADPH dependent microsomal mixed function oxidase system.
When CCl^F is added to hepatic microsomes reduced with sodium 
dithionite a similar spectrum to that obtained with CCl^ is produced 
(Cox et al«j!972a; Uehleke et alrl1973a). The formation of such a. 
difference spectrum with CCl^P in liver microsomes in the presence of
NADPH would indicate that active metabolic intermediates from this 
compound are produced.
There have been reports that CCl^ is metabolised in rabbit 
liver microsomal preparations fortified with NADPH under anaerobic 
conditions to give small amounts of chloroform (Reiner et al«j!972; 
Uehleke et al»jl973a). In view of the similarities between CCl^ and 
CCl^F, CCl^F may be metabolised in a similar manner, to CHCl^F.
NADPH is a necessary cofactor for the formation of the CCl^ 
spectral intermediate with reduced cytochrome P-l+50 and also for 
the microsomal conversion of CCl^ to CHCl^ under anaerobic conditions 
(Reiner et al*,1972; Reiner & Uehleke, 1971)• The possible involvement 
of CCl^F in similar reactions could be investigated by determining
whether the addition of CC1 F to an anaerobic microsomal preparation
3
increases the rate of NADPH oxidation.
The following experiments are reported:
1) The effect of CCl^F on the rate of NADPH oxidation in rat liver 
microsomal preparations under anaerobic conditions, and the effect 
of carbon monoxide on this reaction.
2) Investigations into the formation of the CCl^F reduced cytochrome 
P-U50 complex in the presence of sodium dithionite or NADPH, and the 
effect this complex has on the formation of the cytochrome P-l+50 carbon 
monoxide complex.
3) Investigations into the possible metabolism of CCl^F to CHCl^F under 
anaerobic conditions.
2.2. Materials and. Methods
2.2.1. Materials
CCl^F and CHCl^F from Cambrian Chemicals Ltd., Croydon, Surrey. 
Glucose-6-phosphate, glucose-6-phosphate dehydrogenase, NADP and NADPH 
from Sigma Chemicals Ltd., Kingston-upon-Thames, Surrey.
All other chemicals were of reagent grade and were obtained from 
commercially available sources.
CCl^F or CCl^ were used as solutions in dimethylformamide, (DMF),
( stock solution 500 mM) or used undiluted.
2.2.2. Animals
Male Wistar albino rats (250-300 g), male Golden hamsters 
(130-I50g), male Dutch Cross rabbits (3 kg) and male CF^ mice (20-25g) 
were used.
Hats which were pretreated with sodium phenobarbitone received 
80 mg/kg body weight dissolved in 0.9$ saline, intraperitoneally, 
daily for three days prior to use. Control animals received ah equal 
volume of 0.9$ saline.
2.2.3. Preparation of liver subcellular fractions
Subcellular components were separated by differential centrifugation. 
Animals were killed by cervical dislocation, the livers removed and rinsed 
in a large volume of ice cold 0.2 M phosphate buffer, pH 7.^9 containing 
0.25 M sucrose. The livers were blotted dry, weighed and scissor- 
minced in U volumes of the ice cold buffer solution. The mixture was 
then homogenised using three return strokes of a Potter-Elvehjem,
teflon-glass homogeniser. The tissue suspension was centrifuged, in
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a pre-cooled rotor at k ° 9 at 2,600 r,p.m., for 5 min, (MSE High
speed 18, 8 x 50 ml rotor, 600 g ), The resulting supernatant (super-av
natant A) was carefully removed and stored in ice. All further
centrifugation steps were carried out at 1^°, The pellet was resuspended
in a large volume of the buffer solution and centrifuged for a
further 5 minutes at 2600 r.p.m. The resulting supernatant was discarded
and the pellet representing the nuclear fraction stored in ice. The
supernatant A was then centrifuged at 7,000 r.p.m. for 10 minutes
(MSE High Speed 18, 8 x 50 ml rotor, H,000 g ), to give supernatant
* av
B and a pellet which was washed in the buffer solution and stored
in ice (mitochondrial fraction). A lysosomal fraction and supernatant C
were obtained by centrifuging the supernatant B at 13.500 r.p.m.
for 10 minutes (MSE High Speed 18, 8 x 50 ml rotor, 15,000g ). Theav
crude lysosomal pellet was washed with the buffer solution and
resedimented. Supernatant C was centrifuged at U0,000 r.p.m. for 1 hour
(MSE Super Speed 50, 8 x 25 ml rotor, 10^p00g ) to give a cytosolav
fraction and a microsomal pellet. The pellet was washed in the buffer 
solution and stored at 1+°.
In experiments where only a 15,000 g supernatant or a microsomal
fraction was required, the whole liver homogenate was first centrifuged
at 13.500 r.p.m. (l5000g ) for 20 min. to remove unwanted cellav
components. The resulting supernatant was either used directly or 
a microsomal fraction prepared by centrifuging at if0,000 r.p.m. for 
1 hour.
Protein determinations were made by the method of Lowry et al*
(1951) using a bovine serum albumin standard.
Cytochrome P-^50 was determined using the method of Omura & Sato 
(l96Ua) using a Perkin Elmer, model 356, or a Pye Unicam SP 1800
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. . .  . . - 1 - 1  spectrophotometer. An extmcition coefficient of 91»1 mmole cm
was used (Omura & Sato 196*ib).
2.2.k. Measurement of substrate-induced NADPH oxidation under anaerobic
conditions
NADPH oxidation was monitored in rat liver microsomal suspensions 
from phenobarbitone pretreated rats, in 0,066 M tris-HCl buffer, pH l.b,
made anaerobic by bubbling the suspension for 5 minutes at 4° with oxygen-
free nitrogen. The microsomal protein concentration was 0.5 mg/ml. The 
rate of decrease in the NADPH absorption peal: at 3^0 nm was monitored
at 37° in stoppered 1 cm glass cuvettes using a Perkin Elmer spectro­
photometer, model 356. The rate of NADPH oxidation was measured in the 
absence and presence of CCl^F in alternate samples. Additions of CCl^F 
(in DMF) were made immediately prior to the addition of NADPH (66 pM).
The mean value for tbs initial rate of NADPH oxidation in the 
absence of CCl^F (endogenous rate) was substracted from the individual 
test values. Absolute values were obtained using an extinction 
coefficient for NADPH of 6.2 mM ^ cm ^ (Bergmeyer, 1963).
The effect of carbon monoxide on the rate of NADPH oxidation in 
the presence of CCl^F was determined by bubbling the anaerobic microsomal 
suspension for 30 seconds with carbon monoxide before the addition of 
CC13F and NADPH.
2.2.5. Formation of the CCl^F-reduced cytochrome P-^50 complex
The formation of this complex was investigated at 37° in liver 
microsomal fractions from phenobarbitone pretreated rats, suspended 
in tris-HCl buffer pH J.b (l or 2 mg protein/ml)- The fractions were
made anaerobic as described in 2.2.^. Anaerobiosis was checked using 
an oxygen electrode.
6 ml of the microsomal suspension was divided equally between two
1 cm glass cuvettes, the head space blown with nitrogen, and the cuvettes 
stoppered. The cuvettes were then placed into a heated cell holder,
at 37°, in a spectrophotometer (Perkin Elmer, 356, or an Aminco DW 2) 
and left to equilibrate for a few minutes. A base line between 500 and 
380 nm was then recorded. Sodium dithionite or NADPH (approximately
2 mg) was added to both the test and the reference cuvettes, followed 
immediately by the addition of CCl^F or CCl^ - (injected as a solution in 
DMF into the bottom of the cuvette using a 10 pi g-l-.c. syringe). An 
equal volume of DMF was added to the reference cuvette. The cuvettes were 
shaken and the spectrum between 500 and 380 nm scanned repeatedly for
up to 20 minutes. After this period the test cuvette was bubbled with 
carbon monoxide for 30 seconds and the cytochrome P-U50 carbon monoxide 
spectrum recorded. Experiments were carried out using various CCl^F 
concentrations and an "apparent Km" value was obtained by plotting the 
reciprocal of the initial rate of formation of the peak at ^52 nm, against 
the reciprocal of the substrate concentration.
A second series of experiments was carried out where anaerobic 
microsomal preparations were bubbled with carbon monoxide immediately 
before the addition of NADPH or CCl^F. The spectrum between 500 and 380 nm 
was scanned repeatedly for 15 minutes. After this period the test cuvette 
was bubbled with carbon monoxide for 30 seconds and the resulting spectrum, 
recorded. Control experiments in the absence of CCl^F were also run.
2.2.6. In vitro incubation experiments
The composition of a typical incubation experiment containing one of 
the subcellular fractions, prepared as described in 2.2.3., or a whole 
liver homogenate was:
Tissue sample; protein concentration 8 mg/ml
NADP+ 1.5 mM
Glueose-6-phosphate 3.0 mM
Glucose-6-phosphate dehydrogenase 2 units
CC13F or CCl^ 10 mM
Incubations were carried out in 0.2 M phosphate buffer, pH J . k *
The final incubation volume was 10 ml.
Incubations were carried out in the apparatus shown in Fig. 2.1.
The flasks containing the microsomal suspension and the components of the 
NADPH generating system were evacuated with a vacuum pump and then flushed 
with nitrogen. This procedure was repeated ten times to ensure 
anaerobiosis.
The substrate, CC13F or CCl^was then injected into the incubation 
medium through the self-sealing stopper, using a precooled 10 y 1 g-l.c. 
syringe. The syringe was cooled to facilitate the injection of volatile 
CC13F. The flasks were shaken, clamped in a waterbath at 37°, and. 
incubated with shaking. (100 revs/min.) for periods up to 1 hour. The 
reaction was stopped by cooling the flasks in ice. The incubations were 
extracted with n-heptane (5 ml) and the extracts analysed by g-l,c.
All incubations were carried out in duplicate or triplicate.
Other incubation experiments performed with this incubation system 
in which the following parameters were varied:
Fig. 2.1. Experimental apparatus used in the in vitro incubation
experiment s
Vacuum
self-
sealing
rubber
septum
incubation medium
a) absence of NADP*
b) the concentration of individual components of the NADPH 
generating system was alteredJ
c) time of incubation
d) microsomal protein concentration
e) substrate concentration^
f) with sodium dithionite (2 mM) or FMN (2 mM)#
g) in the presence of air, oxygen, or carbon monoxide, ( a gas
cylinder of one of these compounds was substituted for the
nitrogen cylinder during the flushing procedure)
h) with a microsomal fraction from phenobarbitone pretreated 
rats,
i) in the presence of SKF 525A (*i mM) or metyrapone (2 mM),
j) a mixture of CCl^F (10 mM) and CCl^ (5mM)^
k) with microsomal fractions from various animal species.
2*2.7. Gas-liquid chromatrographic analysis of the n-heptane extracts
All extracts were kept at in stoppered flasks before being 
analysed. The procedure adopted was a modified version of that 
reported by Cox (1972)*
A Pye Unicam model 10^ gas chromatograph fitted with a Ni 
electron capture detector was used. The column was 15# squalane on a
celite solid support, 80-120 mesh. The copper column tubing was
0.32 cm. in diameter and 2 m long.
The carrier gas was oxygen-free nitrogen. The operating conditions were
as follows:
flow rate 66 ml/min
Oven temperature 60°
Detector temperature 150°
Detector pulse space 150s 
Backing off range x 100 
Injection volume 5 U 1
A Honeywell chart recorder was used, with a chart speed of 1+0 in /h.
Fig. 2.2. shows the separations achieved after injection of a sample 
containing CCl^F, CHCl^F, CCl^ and CHCl^. Peak area measurements were 
obtained by multiplying peak height x width at half the height. 
Absolute concentrations were read off calibration curves obtained by 
plotting peak area against the concentration of a series of freshly 
prepared standard solutions. Calibration curves for CHCl^F, CCl^F, 
CHCl^ and CCl^ are shown in Figs. 2.3a, b, c, and d.
2.2.8. Determination of mass spectra
Mass spectra were determined using a LKB model 2091 mass 
spectrometer fitted with a Pye Unicam gas-liquid chromatograph. The 
column used was the same as that already described in 2.2.7. The 
detector for the g-l.c. was the ion detector of the mass spectrometer 
itself. The procedure adopted to concentrate the n-heptane extracts 
from the microsomal incubations for mass spectral analysis is 
described in Appendix 1. 10y 1 aliquots of the concentrated test
solution were injected into the g-l.c. and mass spectra were obtained 
for each peak on the g-l.c. trace.
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2.3. Results
2.3.1. CCl^F-induced rate of NADPH oxidation under anaerobic conditions _3 -------------------------------      :--------------------------------------------------------------------------------------;-— ---------------------- -----
A typical experiment is shown in Fig. 2.i|a. In liver microsomal 
preparations from phenobarbitone pretreated rats a measurable rate of 
NADPH oxidation was recorded in the absence of added substrate. A 
rate of 10.1 n mole/min/mg protein was obtained (endogenous rate). In 
the presence of CCl^F an increased rate was reported of 13.2 n mole /min/mg 
protein. The increase in rate due to CCl^F was therefore 3.1 n mole/min/mg 
protein*DMF had no effect on the rate of NADPH oxidation. The addition 
of carbon monoxide to the incubation medium caused a 83.8$ inhibition 
of the endogenous rate and completely inhibited the increase in rate due 
to CC13F (Fig. 2.U.b).
2.3.2. Formation of the reduced cytochrome P-^O-CCl^F complex
On the addition of CCl^F to sodium dithionite-reduced rat liver 
microsomal suspensions a Soret maximum at b ^ 2 nm was observed in the 
difference spectrum (Fig. 2.5*0 • The peak appeared within 30 seconds 
and increased steadily with time. After 10-15 min , depending bn the 
substrate concentration, a maximum absorption was obtained.
Carbon tetrachloride produced a similar spectrum to that of CCl^F 
(Fig 2.6a) but was only one third of the magnitude and had a Soret 
maximum at k 5 k nm. The peak at k5*+ nm reached a maximum after 6-8 min 
of incubation. The addition of CCl^ to anaerobic rat liver microsomal
preparations reduced with NADPH instead of sodium dithionite produced
..... y
a very similar spectrum (Fig. 2*6 b). This peak formed at a very similar 
rate to that formed in the presence of sodium dithionite but was about
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50$ smaller.
The addition of CCl^F to NADPH-reduced anaerobic microsomal 
preparations produced a similar spectrum to that obtained using 
sodium dithionite (Fig. 2.5b)with a Soret maximum at 1+52 nm. The 
peak reached a constant maximum extinction value in 10 - 15 min.j 
which was 50-70$ smaller than that obtained using sodium dithionite, 
but was twice the magnitude of the equivalent spectrum obtained for •
CCl^. The initial rate of formation of these complexes was much 
higher for CCl^F than for CCl^ (Fig. 2.7.).
The addition of air to the anaerobic incubation medium after the 
formation of the 1+52 or I+5I+ nm absorption peaks for CCl^F and CCl^ 
respectively resulted in immediate loss of the peaks. When anaerobiosis 
was restored the peaks reformed slowly.
On the addition of carbon monoxide to a microsomal suspension 
after the formation of the spectral peak at 1+52 nm with CCl^F and 
NADPH or sodium dithionite, a peak at 1+50 nm was obtained. This 
peak was much smaller than that obtained when the microsomal preparations 
were bubbled with carbon monoxide after incubation for the same time 
in the absence of CCl^F (Fig 2.8a). The results obtained are summarised 
below:
CC13F cone11. (mM) 0 0.1 1.0 2.0 1+.0
1+52 nm peak, AE at 15 min. 0 0.01+0 0.066 0.066 0.063
CO peak AE 1+50-1+90 nm at 15min.0.11 0.099 0.080 0.066 0.01+1+
$ reduction in CO peak --  23.2 30.8 32.6 61.6
With increasing CCl^F concentration'the decrease in the resulting carbon 
monoxide spectrum became more marked. Although there was only a small 
variation in the magnitude of the 1+52 nm peak over the concentration range
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taken, the rate of formation of these peaks was dependent on the 
CCl^F concentration. An "apparent Km" value from initial rate
_3
measurements was 1.2 x 10 M (Fig. 2.9.)*
A small amount of cytochrome P-^20 was formed in incubations 
with CCl^F but it was not significantly higher than in controls.
A summary of the experiments carried out to determine the mechanism 
of the CCl^F inhibition of the carbon monoxide spectrum is shown below:
Experiment Additions to anaerobic incubation % of 1+50 nm carbonof tissue and NADPH generating monoxide peak at
system at: 15 min.
0 min 15 min
1 - CO 100
2 CC13F CO 38.1+
3 - CO + cci3f 100
1+ CO + cci3f CO 100
CC13F cone11 1+ mM.
Incubations in which CCl^ was used gave very similar results to those 
obtained with CC^F. An 80$ reduction in the magnitude of the carbon 
monoxide spectrum over controls was recorded after a 15 min incubation 
with 1.5 mM CCl^ (Fig 2.8 b).
2.3.3. In vitro incubation experiments
Gas-liquid chromatographic analysis of the n-heptane extracts from 
1 h incubations of CCl^ with rat whole liver homogenates fortified 
with an NADPH generating system under anaerobic conditions, showed the 
presence of chloroform. The analysis showed that 2% of the CCl^ was 
metabolised to chloroform.
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G-l.c. analysis of the extracts obtained from 1 h incubations of rat 
whole liver with CCl^F under similar experimental conditions gave a . 
small peak with a retention time of 1 2 h s (Fig 2.10.)» The peak 
was only measurable at the detection limits of the analysis technique 
but was found to have an identical retention time to that of CHCl^F. In
• • • •"fr* •the extracts of the incubations where tissue, NADP , or CCl^F, were omitted 
no peak was obtained.
Mass spectral analysis of the g-l.c. peak representing the metabolite 
is shown in Fig. 2.11a. The spectrum shown indicates mass ions not present 
in a background scan. The mass spectrum obtained from a standard solution 
of CHCl^F is shown in Fig. 2.11b. Comparison of these mass spectra show 
them to be identical and show the presence of mass ions between: 101 and 10V 
82-85, 66-69, ^T“^9 and at 31 mass units. These ions all represent expected
ion fragments from CHCl^F. The most abundant ion is at 66 mass units,
35 + . . .representing CC1 F . The mass spectrum obtained for CCl^F is shown m
Fig. 2.12. and shows similar ion fragments to those obtained for
CHClgF, however the relative abundance of the individual ions is different.
In this case the most abundant ion was found at mass 101 representing
35 + .
CCl^ F . These results give positive evidence that the metabolite was
chci2f .
No loss of CCl^F was detected during the incubation procedure and the 
efficiency of the extraction of CCl^F and CHCl^F from the incubation medium 
was shown to be 100$ (see Appendix 2 and 3).
Fig. 2.13. shows the results obtained after 20 min incubations of 
various subcellular fractions with CCl^F* The majority of the metabolising 
activity was found associated with the microsomal fraction* In all other 
experiments a 15000 g supernatant or a microsomal fraction were used.
f iff»2.10. G 1,c« analysis of an n heptane extract of rat whole liver homogenat
after incubation with CCl^F
CCI3F
Standard solution
c a 3F
-Time
Metabolite
n~heptane extract
CCl^F cone11 10 mM Incubation time 60 min.
Ifleubation contained 2  g of whole l i v e r  homogenate
Fig. 2.11. Mass spectra of the metabolite obtained after anaerobic incubation 
CC1 F with NADPH-reduced microsomal preparations at 37° ■» and 
of a standard solution of CHCl^F
metabolite
601*0 50
Mass units
8010 20 30 11070 10090
standard CHCl^F solution
602010 . 30 8050 70 90 110100
Mass units
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The optimum concentrations of components of the generating system
*{•
were determined by altering the concentrations of NADP and glucose-6-phos- 
+
phate. At NADP concentrations less than 0.75 mM a slight reduction 
in the amount of metabolite formed was recorded. At NADP+and glucose-6-phosphat 
concentrations higher than 1.5 and 3.0 mM respectively no increase 
in CHCl^F formation was recorded.
The rate of formation of CHCl^F is shown in Fig. 2.1^. The 
formation of metabolite was approximately linear for the first ten 
minutes of incubation and continued to be produced up to 25 min.
Some variation was found between the amount of metabolite formed 
between different microsomal preparations, but samples from the 
same preparation gave reproducible results.
Increasing the concentration of microsomal protein Caused 
a concomitant increase in the amount of metabolite formed (Fig. 2.15).
Linear regression analysis of values obtained gave a straight line.
Increasing the substrate concentration increased the amount of 
metabolite formed* High concentrations of CClgF (20-30 mM) were 
required to obtain maximal activity. Lineweaver-Burk plots of 
the reciprocal of the initial rate of CHCl^F formation against the 
reciprocal of the substrate concentration gave straight lines 
(Fig. 2.16). Determinations of kinetic constants gave a Km value of 
1.9 mM and a V_„„ value of 0.13 n mole/min/mg protein.
IUcL.X
When sodium dithionite was incubated with CCl^F in the absence 
tissue or NADPH trace amounts of CHCl^F were detected. On addition: 
of sodium dithionite to the incubation medium in the presence of 
tissue, NADPH, and CCl^ the yield of CHC12F was increased by approximately
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The addition of FMN [2 mM) to the incubation medium caused a 
50$ increase in the amount of CHCl^F formed. In the absence of tissue 
no metabolite was formed in incubations with FMN.
The effects of various compounds on the anaerobic metabolism of 
CCl^F to CHCl^F in rat liver microsomal fractions are shown below:
Number of experiments % Inhibition
CO (101 K.Pa) 6 100
Compound SKF 525A (*i mM) 3 50
Metyrapone (2 mM) 3 TO
Oxygen (101 K.Pa.) 6 75
Air (101 K.Pa) 6 50
CCl^ (5 mM) 3 80
CCl^F cone 10 mM, U mg microsomal protein/ml,incubation time 20 min. 
Results are expressed as % inhibition compared with controls.
In rat liver microsomal preparations from animals pretreated with 
sodium phenobarbitone a 100 to 200 % increase in the concentration of 
cytochrome P-U50 was measured. In the majority of experiments the 
amount of CHCl^F produced after 20 min incubations was increased with 
increased cytochrome P-^50 concentration. A summary of the results 
obtained is shown below:
63
% increase % increase 
in CHC1 F in cyto- 
formed chrome P-H50
10 0.56 + 0.08*0.33±0.01* 1.1 + 0.1** 0.6 ±0.1** 70 83
Values ± SEM * p « < 0.05 **p = < 0.01
These results indicate a direct relationship between the concentration of 
cytochrome Pi-50 and the amount of metabolite produced. However in a few
experiments a large increase in the cytochrome P-^50 concentration was
measured yet an insignificant increase in the amount of metabolite formed 
was recorded.
The results of experiments into the anaerobic metabolism of CCl^F 
in microsomal fractions from various animal species are summarised in the 
following table; '
Rat Rabbit Mouse Hamster
No.experiments 10 3  ^ 3
CHCl^F formed/
incubation (pg) 7*3 6.6 7*1 9*1
% inhibition by CO 100 100 100 100
% inhibition by 02 75 100 100 not done
CCl^F cone1. 10 mM^microsomal protein concentration 8 mg/ml-
The amount of CHCl^F produced after a 20 min incubation period was 
approximately the same in all species tested.
NOf CHClgF formed Cytochrome P-l*50
Experiments t cone
p g/min n mole/mg)(protein
Test Control Test Control
2.b. Discussion
Data on the metabolism of xenobiotics in vitro under anaerobic 
conditions is veil documented for reactions such as the reduction of nitro 
compounds to primary amines and azo compounds to hydrazo or primary amine 
derivatives (see Mitchard, 1971)* The metabolism of these compounds has 
been shown to be associated with both the liver microsomal fraction and 
the cytosol. The microsomal mediated reaction requires NADPH as cofactor 
(Mueller & Miller, 19^ -8; 19*+9; 1950; Fouts & Brodie,1957)•
The addition of CCl^F to anaerobic liver microsomal preparations 
caused a small but significant increase in the rate of NADPH oxidation.
In the absence of any effect by the solvent DMF this indicated that CCl^F 
may also be metabolised under anaerobic conditions by a liver microsomal 
system. The total inhibition of the CCl^F-induced rate of NADPH oxidation 
by carbon‘monoxide suggested the involvement of cytochrome P-A50. The 
endogenous rate of NADPH oxidation measured under anaerobic conditions would 
also appear to be mediated in part by cytochrome P-150 as this rate was 
also inhibited by cafbon monoxide. This rate may represent the reductive, 
metabolism of endogenous substrates, however there are no reports in the . 
literature of investigations into this type of reaction.
CCl^F and CCl^ both produced difference absorption spectra in sodium 
dithionite-reduced microsomes with maxima at b52 and 1+5*+ nm respectively. 
This is in agreement with the findings of Cox et al,(1972b )and Reiner 
& Uehleke (1971)* The reports by McLean (1967) and Reiner & Uehleke (.1971) 
that a similar spectrum is produced with CCl^ in the presence of NADPH 
under anaerobic conditions were confirmed. Reiner & Uehleke (1971) reported 
that the maximum at b^k nm in NADPH-reduced rabbit liver microsoaes was
TO - QO% of that produced in sodium dithionite reduced microsomes.
In experiments here a similar trend was observed but the spectral 
maximum in NADPH-reduced microsomal preparations was 50% of that in the 
presence of sodium dithionite. CCl^F produced a spectral maximum at 
^52nm in NADPH-reduced microsomes1 and this spectrum was 50-?0$ smaller 
than that obtained in the presence of sodium dithionite. The 
proposal that these spectra represent the interaction of an active 
intermediate with cytochrome P-i*50 resulting from cytochrome P-^50 
mediated metabolism (Ullrich & Schnabel, 1973; Mansuy et al«,197^) suggests 
that CCl^F was activated by the microsomal mixed function oxidase system 
to give such an intermediate.Mansuy et al-(197 )^ have provided evidence 
that the active intermediate which exhibits these spectra is a carbene.
In the case of CCl^F a carbene would be formed in the following manner:
CC1J > CC1F;
The CCl^spectrum observed in the-presence of NADPH was smaller than 
that produced by CCl^F which indicates that either more of the intermediate 
was formed in the case of CCl^F, that the complex with CCl^ is less stable 
and dissociates rapidly, or that the extinction coefficients of the two 
complexes are significantly different. It would seem unlikely that the 
latter is the case. Both the CCl^F—and CCljj-induced spectra in 
NADPH-reduced microsomal preparations disappeared on the introduction of 
oxygen indicating that either the binding is reversible in nature, or that 
the complexes formed are easily oxidisable. It has been suggested that 
the binding site of the active intermediates, resulting from halogenated
hydrocarbon metabolism, with reduced cytochrome P-^50 is the same as that
occupied by oxygen (Reiner & Uehleke, 1971)* The affinity of cytochrome 
P-ii50 for oxygen has been reported to be 10 (Kratz & Staudinger, 1965),
c-
which is much higher than the affinity of the halogenated hydrocarbon compoun
-3with 'apparent Km' values of approx. 10 Me If the binding of halogenated 
hydrocarbon compounds is reversible it is expected that oxygen will 
displace these complexes.
Carbon monoxide is also thought to bind to cytochrome P-l+50 at the 
oxygen binding site (Estabrook et al.,1970). Incubation of CCl^F with 
liver microsomal preparations reduced with sodium dithionite-, or NADPH, 
caused a marked reduction in the carbon monoxide binding spectrum.
No reduction in this spectrum was measured over controls when CCl^F 
was added immediately prior to the addition of carbon monoxide. The 
reduction in the carbon monoxide spectrum must therefore have resulted 
from the interaction of CCl^F with cytochrome P-A50 during the incubation.
No significant conversion of cytochrome P-1+50 to cytochrome P-l+20 was 
observed, and the lack of any evidence that CCl^F causes destruction 
of cytochrome P-l+50 indicates that the complex between an intermediate 
product of CCl^F metabolism and reduced cytochrome P - k 50 competes with carbon 
monoxide for the haem binding site on the cytochrome P-1+ 50 molecule. However 
the poor relationship between the magnitude of the spectral maximum at 
1+52 nm and the resulting carbon monoxide spectrum indicates that the exact 
mechanism is more complicated. In incubations of CCl^F with reduced 
microsomal preparations first bubbled with carbon monoxide the carbon 
monoxide spectrum after 15 minutes was the same as in control experiments 
not containing CCl^F. This suggests that carbon monoxide inhibits the 
formation of the CCl^F metabolite which interacts with reduced cytochrome 
P-l+50 and implies that cytochrome P-l+50 itself mediates the process 
responsible for CCl^F activation.
CCl^-induced destruction of cytochrome P-l+50 has been reported to 
be a result of CCl^-induced lipid peroxidation (Reiner et. al#p.9?2; Sasame 
^  al./L968). The destruction of cytochrome P-l+50 by this mechanism
cannot account for the reduction in the carbon monoxide spectrum 
by CCl^ in this case, as in the absence of oxygen there is no 
possibility of peroxidative reactions taking place. It is therefore 
probable that the explanation for the reduction in the magnitude of 
the cytochrome P-^50 spectrum due to CCl^ is similar to that proposed 
for CC13F.
On incubation of CCl^ with rat whole liver homogenates, fortified 
with NADPH under anaerobic conditions, a 2% conversion to chloroform 
was recorded. These findings are in agreement with those reported 
by Reiner et al* (1972) and Uehleke et al.(1973a) where a similar 
conversion was reported using rabbit liver preparations. These results 
also indicated that the incubation system devised here was viable for 
investigations into the metabolism of CGl^F.
The production of trace quantities of CHCl^F after incubation of 
CCl^F under similar experimental conditions gives direct evidence that 
metabolism of CCl^F occurs. The metabolic activity was found to be 
associated with the microsomal fraction and to be dependent on;the 
presence of NADPH, which suggests the involvement of the microsomal 
mixed function oxidase system. This system is known to be involved in 
the anaerobic reduction of nitro and azo compounds (Gillette et al.,1966 
Hernandez et al»;1967b).
The rate of formation of CHC12F was found to be typical for an 
enzyme mediated reaction, no further increase in product was measured 
after 25 minutes. If the reaction was non-enzymic a more linear 
relationship might have been expected.
In the absence of an electronic integrator quantitative values 
of CHCl^F concentration had to be obtained from peak area measurements. 
With small peaks this technique is liable to considerable error.
Therefore most experiments -were carried out with a 20 minute incubation 
period to obtain maximum peak size without too great a reduction in the 
linearity of the reaction.
It is interesting to note that the rate of formation of the 
metabolite is- similar to the rate of formation of the complex formed 
between CCl^F and reduced cytochrome P-l+50 (cf. Figs. 2.7. and 2.1^.).
A similar observation has been made for CCl^ by Uehleke (1973). 
Determination of the kinetic constant for CHCl^F formation gave a Km value 
of 1.9 this value is similar to the ’apparent Km’ vlaue of 1.2 mM 
obtained for the formation of the NADPH-dependent CCl^F-reduced 
cytochrome P-A50 complex.
Uehleke et al«(l973a) have reported a Km value for chloroform formation
-k
of approximately 1 x 10 M m  rabbit liver microsomes, which could 
account for the considerable inhibition of CCl^F metabolism by CCl^ 
found here. Hernandez et al«(1967a) have reported a Km value for the
_3
azo reduction of neoprontosil in rat liver microsomes of A x 10 M 
which is the same order of magnitude to that obtained for CCl^F here.
The finding by these workers that the azoreductase enzyme could not 
be saturated within the solubility limit of neoprontosil is similar 
to findings here where very high concentrations of CCl^F were required 
to obtain maximal metabolising activity.
Uehleke et_ al,(1973a) reported that on addition of sodium 
dithionite to anaerobic incubations of CCl^ with rabbit liver microsomes 
fortified with NADPH, a 10 - 15$ increase in -chloroform
formation was recorded. A similar trend was observed here using 
CCl^F, however trace amounts of CHCl^F were shown to be produced 
on incubation of CCl^F with sodium dithionite alone indicating 
a non-enzymic conversion of CCl^F. This finding suggests that the 
slight increase in CHCl^F formation in the presence of sodium dithionite 
is not enzyme mediated but purely an additive effect.
The formation of trace amounts of metabolite in the presence 
of sodium dithionite could be interpreted as an indication that the 
active intermediate responsible for the formation of the sodium 
dithionite-reduced CCl^F-cytochrome'P-^50 complex is the same as that 
which gives rise to the formation of the reduced metabolite. If this 
is the case the active intermediate involved in the formation of the 
reduced cytochrome P-^50 complex could not be a carbene, as suggested 
by Mansuy et al* (197*0 ■. as further metabolism of the carbene could not 
give rise to CHCl^F as a product. The other possible intermediates 
involved in the formation of this complex are either a free radical or 
a carbanion:
CC13F + e" — ------- * CClgFV + Cl"
CC12F* + e"  ^ CC12F_
Either of these two intermediates could give rise to CHC12F formation.
A similar scheme has been proposed for CCl^-by Ullrich & Schnabel (1973). 
A carbanion intermediate could easily undergo degradation to give a 
carbene,
>  CC1F: + Cl
and in view of the considerable evidence of Mansuy et al«0-97*+) 
that a carbene is involved in the formation of complexes with reduced 
cytochrome P-U50, it would appear that at least two active intermediates 
from CCl^F are formed.
The addition of FMN to the incubation medium increased the metabolism 
of CCl^F by 50%. There are several reports in the literature that FMN 
increases azoreductase activity (Mueller & Miller 1950; Shargel & Mazel 
1972) and nitroreductase activity (Fouts & Brodie 1957)* These workers 
suggested that the increase was probably because FMN could act as an 
artificial electron carrier between NADPH and the substrate. However 
in experiments here when tissue was omitted no CHCl^F could be detected 
in the presence of FMN and an NADPH generating system.
CHCl^F formation was found to be considerably inhibited by oxygen, 
and to a lesser extent by air. These findings are in similar to those 
reported by Reiner et al.(1972) for the metabolism of CCl^ to chloroform, 
who reported an 80-85% inhibition by air, and a 90% inhibition by oxygen. 
Uehleke et_ al.(1973a) have reported an 86% inhibition of chloroform 
formation by carbon monoxide and a 68% inhibition by 1 mM metyrapone; 
these values are similar to those found here for CHCl^F formation. A 
total inhibition by carbon monoxide and a 70% inhibition by 2 mM metyrapone 
were recorded. Both carbon monoxide and metyrapone are classical inhibitors 
of reactions mediated by cytochrome P-^50, which indicates the involvement 
of this cytochrome in the metabolic pathway. The direct relationship 
between the cytochrome P-^50 concentration and the amount of CHCl^F formed, 
using microsomal preparations from rats pretreated with sodium phenobarbitone 
would tend to support this possibility.
The reductive metabolism of azo compounds has been shown to 
be inhibited by air or oxygen (Fouts et al.,1957) and to be partially 
inhibited by carbon monoxide (Hernandez et al«,1967b). Similar 
results have been reported for the reduction of nitro compounds 
(Fouts & Brodie,1957)• Phenobarbitone pretreatment of animals has 
been shown to increase microsomal azo reductase activity (Hernandez 
et al.>1967b) and microsomal nitroreductase activity (Gillette et al»j 
1968; Carlson & .■Dubois,'1970).
Neoprontosil reduction has been shown to be enhanced l k % in the 
presence of SKF 525A (Shargel & Mazel,1972). Uehleke et al*(1973a) 
reported that 1 mM SKF 525A caused a 15% enhancement of CCl^ metabolism 
to CHCl^j however in experiments here a 50% inhibition of CCl^F metabolism 
in the presence of k mM SKF 525A was recorded. The discrepancy in 
these results could be accounted for by the higher inhibitor 
concentration used here.
There seems to be a great deal of similarity between the 
anaerobic metabolism of CCl^F and CCl^ and there are many similar 
properties to the microsomal enzymes which mediate the reductive metabolism 
of azo and nitro compounds (see Table 2.1).
Two sites have been proposed as the site of azo reduction; 
the flavoprotein NADPH cytochrome c reductase (Mueller & Miller, 19*+8;
19*+9; 1950; Hernandez et alvl967a) and cytochrome P-U50 (Hernandez et aly 
1967b). Cytochrome P-U50 has been proposed as the site of nitro reduction 
(Gillette et al-,1968). The activity of NADPH cytochrome c reductase 
ig unaffected by carbon monoxide, and as a result the partial 
inhibition of azo reduction by this compound was reported by Hernandez
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et al* (l967t)) to be due the inhibition of the cytochrome P-l+50 
mediated metabolism. These workers showed that the cytochrome P-U50 
mediated metabolism was inhibited 100% by carbon monoxide. The total 
inhibition of CCl^F metabolism by carbon monoxide indicates that it 
is the cytochrome P-^50 molecule and not the flavoprotein which is the 
site of metabolism. It has been reported that the anaerobic metabolism 
of CCl^ is not totally inhibited by carbon monoxide (Reiner et_ al-,1972), 
it is therefore possible that a very small proportion of CCl^ metabolism 
is at the flavoprotein site. Experiments by Slater & Sawyer (l97ib) 
on the effects of selective inhibitors on the CCl^-induced lipid 
peroxidation under aerobic conditions suggested that it is the flavoprotein 
site which is responsible for the initiation of CCl^-induced lipid 
peroxidation.
2.5* Summary
CCl^F has been shown to form active metabolic intermediates which 
bind to NADPH-reduced cytochrome P-l+50 to give a spectral maximum at 
1+52 nm. Under similar conditions CCl^F has been shown to be metabolised 
to small amounts of CHCl^F. The anaerobic metabolism of CCl^F is very 
similar to that reported for CCl^ and for the microsomal reduction of azo 
and nitro compounds. The site responsible would appear to be on the 
cytochrome P-^50 molecule.
All animal species tested showed similar levels of activity.
The metabolism was inhibited by oxygen but was only partially 
inhibited by air.
Chapter 3
The interactions of trichlorofluoromethane with liver 
microsomal preparations under aerobic conditions
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3.1. Introduction
The, finding that CCl^F is metabolised in an NADPH”fortified 
rat liver microsomal system under anaerobic conditions to CHCl^F, 
and that CHCl^F formation was not totally inhibited by air or oxygen, 
indicated that active intermediates of CCl^F could be formed under 
aerobic conditions. As a result the oxidative metabolism of CCl^F 
in vitro became a possibility. There have been reports in the literature 
that CCl^ is metabolised under aerobic conditions in yitro to CRCl^
(Butler, 1961) and to carbon dioxide (Seawright & McLean, 1967)*
By analogy similar products would be expected for CCl^F.
CCl^F has been shown to give a type I binding spectrum with the 
cytochrome P-^50 of rat liver microsomes (Cox et al., 1972a}. Such 
spectra are thought to represent the binding of substrate to the active 
site of the cytochrome P-H50 molecule (.Schenkman et al. , 1967)9 and are 
thought to be a prerequisite of oxidative metabolism.
Estabrook et al. (.1971) have reported that the addition of 
substrates of the hepatic mixed function oxidase system e.g. hexobarbitone, 
to microsomal suspensions containing NADPH and oxygen giye a shoulder 
on the side of the cytochrome b,_ spectrum in the region of 4^0 nm. Such 
spectra have been interpreted as representing the formation 
of an oxygen-substrate intermediate with cytochrome P-^50. The 
production of such a spectrum with CCl^F would be a further indication 
that this compound may be metabolised oxidatively.
The requirement of microsomal mixed function oxidase-mediated 
metabolism on NADPH and oxygen makes it possible to inyestigate the
oxidative metabolism of substrates by monitoring the cofactor 
requirements (Cooper et al., 1963; Wolf et al., 1975; Netter & Kahl, 
1969; Jeffery & Mannering, 197*+; Narisimhulu, 1971)* Substrates 
metabolised by the mic^omal mixed function oxidase system should 
increase the rate of oxygen consumption and NADPH oxidation and the 
requirement for these cofactors should be in the ratio of 1 : 1.
RH + NADPH + H+ + C>2  > ROH + HgO + NADP+
In view of the problems in monitoring substrate disappearance 
or product formation with a volatile compound like CCl^F, the 
monitoring of cofactor requirements was used here to obtain evidence 
for oxidative metabolism.
The following experiments are reported:
1. In view of the.high volatility of CCl^F the stability of the type I 
binding spectrum at various temperatures, and in the presence of an 
NADPH generating system,was investigated.
2. Whether CCl^F (and CCl^) give the kbO nm difference spectrum in the 
presence of NADPH.
3. Whether CCl^F (and CCl^) increase the rate of oxygen uptake and 
NADPH oxidation when added to liver microsomal preparations.
U. The effects of various compounds, including classical inhibitors 
of cytochrome P-*+50, on the rate of oxygen uptake and NADPH oxidation 
in the presence of CCl^F.
3.2. Materials and Methods
3.2.1. Animals
Male Wistar albino rats (.200 g) or male rabbits, in-bred strain, 
fed a standard laboratory diet were used. Rats pretreated with sodium 
phenobarbitone received 80 mg/kg i.p. in 0.9$ saline daily for three 
days before use. Rabbits received 20 mg/kg sodium phenobarbitone i.p.
for 5 days prior to use. Control animals received Q.9$ saline.
3.2.2. Preparation of liver microsomal fractions
Liver microsomal fractions were prepared according to the method 
of Netter (i960). Microsomal preparations were either used on the day 
of preparation or were stored in 0.02 M tris-HCl buffer pH 7»*+3 
containing 0.25 M sucrose and 5**+mM EDTA, at -20° at a protein 
concentration of approximately 20 mg/ml. Stored microsomes were used 
within two weeks of preparation. Protein determinations were made according 
to the method of Lowry et al. (1951). Cytochrome P-*f50 was determined
by the method of Omura & Sato (l96*+a).
3.2.3. Measurement of binding spectra
Substrate induced binding spectra were measured by the method of 
Schenkman et_ al. (1967)» using a Perkin Elmer 356 or an Aminco D.W.2 
spectrophotometer.
The stability of the type I binding spectra was investigated in 
open 1 cm glass cuvettes held in a heated cell compartment in the 
spectrophotometer. The microsomal protein (.1 mg/ml) was suspended 
in 0.066 M tris-HCl buffer pH 7.*+. CCl^F was added as a solution in 
dimethylformamide and injected into the bottom of the test cuvette
78
using a 10 y 1 g-l.c. syringe. The spectrum between 500 and 380 nm 
was then scanned repeatedly for periods up to 1 h.
A comparison was made between the magnitude of the CCl^F type I 
binding spectrum at 10°and 37  ^at various substrate concentrations.
The spectral binding constant (Ks) was obtained by plotting the 
reciprocal of the magnitude of the CCl^F induced difference absorption 
between k 2 2 and 390 nm against the reciprocal of the substrate 
concentration.
The stability of the CCl^F induced type I binding spectrum was also 
investigated at 37° in the presence of a NADPH generating system 
[glucose-6-phosphate (3.3 mM), glucose-6-phosphate dehydrogenase 
■■('0.5 units), NADP (66 yM), nicotinamide (.2 mM)] , by repeated scanning 
of the spectrum between 500 and 380 nm. Both the test and reference 
cuvettes contained the components of the generating system. CC3.^ Ff 
as a solution in dimethylformamide, was added to the test cuvette 
only. The stability of the CCl^ and hexobarbitone type I spectra 
were also investigated under these conditions.
3.2.^ 4. Measurement of the spectral intermediate at ^ 0  nm
The formation of this intermediate was investigated using the 
method of Estabrook et al.(1971)• Rat liver microsomal fractions from 
phenobarbitone pretreated animals were suspended at a protein concentration 
of 1 mg/ml, in 0.066 M tris-HCl buffer pH 7.^5 containing [glucose-6- 
phosphate (3.3 mM), glucose-6-phosphate dehydrogenase (.0.5 units), 
and nicotinamide (2 mM)] . 6 ml of this suspension was divided equally
between two 1 cm glass cuvettes fitted in a heated cell compartment 
(37°) in the spectrophotometer. A base line between 500 and 370 nm
was run. NADP+ was then added to the test cuvette to give a cuvette 
concentration of 66 PM and the cytochrome b_ spectrum obtained. The 
substrate (CCl^F or CCl^) dissolved in dimethylformamide was then 
added to both cuvettes to give a concentration of 1 mM, and the difference 
spectrum scanned with time. Experiments using hexobarbitone (l mM) were 
also run.
The activity of the NADPH generating system was checked by measuring 
NADPH formation at 3^0 nm.
3.2.5* Measurement of oxygen concentration
Oxygen concentration was measured using a gold micro-electrode 
developed by Erdmann(1971) and constructed according to the method of 
Heindenreich et al. (1970). Fig. 3.1. is a diagramatic cross section 
of the electrode. The reference electrode was a silver/silver chloride 
wire.
To obtain a suitable polarisation voltage for this electrode system 
a polarisation voltage against amperometric response curve was determined. 
The amperometric response of an equilibrated solution of known, oxygen 
content was measured at various polarisation voltages, Fig. 3.2.
The electrode response was shown to be constant between - 800 and -1^00 mV. 
In these experiments a polarisation voltage of -85O mV was used.
The polarisation voltage and amplification of signals was achieved 
using a Transidyne General, model 1200, chemical microsensor (Transidyne 
General Corp., Ann Arbor, Michigan, USA). Changes in signal were displayed 
using a Hartmann and Braun chart recorder (Hartmann & Braun A.G. Frankfurt).
A diagramatic section of the gold micro-electrode
100 m
(a) Glass coated gold electrode w ire , with 
a tip coated with hydrophilic resin
(b) sealing glue
(c) gold w ire
(d) copper conducting w ire
ur
ve
 
of 
po
la
ri
sa
ti
on
 
vo
lt
ag
e 
ag
ai
ns
t 
am
pe
ro
me
tr
ic
 
re
sp
on
s
ooo ooon
ooC\]
o
(yu) asuodsay
80
0 
12
00
 
16
00
 
20
00
 
Po
la
ri
sa
ti
on
 
vo
lt
ag
e 
fm
V)
Assays were carried out in 1 cm glass cuvettes held in a heated 
cuvette holder. The electrodes were manottv^red in and out of the 
cuvettes using a micromanipulator (W. R. Prior and Co., Bishops Stortford). 
Chart recorder readings were converted into oxygen concentration using a 
calibration curve obtained by equilibration of tris-HCl buffer^pH J,b 
at 37? with various : 0^ gas mixtures, and plotting recorder deflection 
against oxygen concentration. The oxygen concentration of a solution 
containing 21 % oxygen was taken to be 0.21^ 4 mM at 37° at atmospheric 
pressure. Fig. 3.3. shows the calibration curve used.
This electrode system was shown to give identical results to the 
conventional Pt/Ag 'Clarke type1 electrode, but was preferred here for 
practical reasons (see Wolf et al., 1975).
3.2.6. Measurement of substrate-induced oxygen uptake
To ensure an even coating of silver chloride on the reference 
electrode, the electrodes were left to equilibrate in 0.9% sodium chloride 
for 30 minutes before use.
Suspensions of fresh or stored rabbit or rat liver microsomal 
preparations, protein concentration 0.59 1.0 or 1.5 mg/ml, in 0.066 M 
tris-HCl buffer pH 7*^ containing ethylenediaminetetraacetic acid 
(130 pM), glucose-6-phosphate (3.3 mM), glucose-6-phosphate dehydrogenase 
(0.5 units) and nicotinamide (2 mM) were equilibrated in the cell holder 
at 37°* The steady state position of the recorder pen was noted, and then 
the electrodes removed. NADP+solution (20 pi) was added to give a 
concentration of 66 pM, the cuvette gently shaken by inversion and the 
electrodes replaced. The endogenous rate of oxygen uptake was recorded
C alibration curve of reco rd er deflection against 
oxygen concentration
9 0
6 0
3 0
- 40 0 Cone11
Recorder readings were obtained after equilibration of 0.066 M tris-HCl 
buffer (pH 7.^) at 37 with various gas mixtures. These were: nitrogen 
alone, 0.202 x 10-i* M oxygen (2.0# 02 98# N2), 1-2 x 10“%  oxygen 
(11.8# 02 88.2# N2), and 2.1^ x 10~%1 oxygen (air)
for a few minutes. The electrode was again removed and substrate 
(CCl^F, CCl^ or hexobarbitone) added using a 10 y 1 g-l.c. syringe, 
and the cuvette shaken. The electrode was replaced and the new rate of 
oxygen uptake recorded until anaerobiosis.
Experiments at various substrate concentrations in duplicate 
or triplicate were carried out. This technique gave an endogenous 
(control) and a substrate-induced (test) rate of oxygen consumption 
for each determination. Using an alternative technique separate 
samples were -used to determine endogenous oxygen uptake and the 
oxygen utilization in the presence of substrate, but because of 
slight variations in the endogenous rate from sample to sample the 
former technique was preferred.
Substrate induced oxygen consumption was obtained by subtracting 
the endogenous rate from the rate in the presence of substrate. Absolute 
values were then obtained using a calibration curve (Fig. 3.3.). The 
kinetic parameters Km and Vmax were obtained by plotting the reciprocal 
of the substrate-induced oxygen consumption against the reciprocal of 
the substrate concentration,, according to the method of Lineweaver &
Burk (193*0.
It was assumed that the substrates used did not affect the 
endogenous rate of oxygen consumption.
3.2.7* Measurement of substrate-induced NADPH oxidation
NADPH oxidation was monitored in aerobic microsomal suspensions 
in 0.066 M tris-HCl buffer pH 7*** containing 130 yM ethylenediaminetetra- 
acetic acid and 2 mM nicotinamide. The protein concentration was 0.5 mg/ml. 
The rate of decrease in the NADPH absorption peak at 3*+0 nm in the presence
or absence of substrate (CCl^F or hexobarbitone) was measured at 37° 
as described in 2.2.k. Kinetic parameters were obtained by plotting 
the reciprocal of the substrate induced rate of NADPH oxidation against 
the reciprocal of the substrate concentration.
The rate of substrate induced oxygen uptake and NADPH oxidation 
were investigated in the presence of:-
a) 0.3 inM metyrapone, added as a solution in DMF prior to the
. +
addition of NADP or NADPH,
b) In microsomes bubbled for 1 min with carbon monoxide/oxygen 
gas mixtures of 100% CO, 80% CO : 20% 0^, or 30% CO : 70% O^. The 
gas mixtures were prepared using a gas mixing balloon. The oxygen 
content of the mixture was monitored,where possible, using the oxygen 
electrode.
c) in the presence of cyanide. Various concentrations of KCN 
were added in aqueous solution to give cuvette concentrations from 
0.5 to V mM. KCN solution was added to the microsomal suspension 
immediately before the addition of NADP+ or NADPH.
d) NADH (66;y M) was used instead of NADP+ or NADPH,
e) 10 u 1 of a catalyse solution (1000 units) was added prior to 
the addition of NADP+ or NADPH.
3.2.8. Determination of lipid peroxidation
Lipid peroxidation in rabbit liver microsomal preparations was 
determined using the method of Ernster & Nordenbrand (.1967), by 
monitoring the rate of malondialdehyde formation using the thiobarbituric 
acid reaction and the subsequent absorption peak at 535 nm. Determinations
were carried out in microsomal suspensions in 0.066 M tris-HCl buffer, 
pH 7*^9 at a protein concentration of 2.5 mg/ml.
Lipid peroxidation induced by CCl^F (l mM) or CCl^ (l mM) was 
investigated in the presence and absence of 130 pM ethylenediaminetetra- 
acetic acid. The malondialdehyde levels measured in incubations 
without an NADPH generating system were subtracted from those containing 
NADPH and absolute values were obtained using a calibration curve.
3.3. Results
3.3.1. Stability of the type I binding spectrum
The magnitude of the type I binding spectrum of CCl^F obtained 
at either 10° ( i.e. 13° below the boiling point of CCl^F) or at
37° was found to be the same (Fig. 3.^ 4.). The rate of loss of the
spectrum was not faster at 37° and at both temperatures was slow.
The effect of increasing the substrate concentration on the magnitude 
of the type I spectrum at 37° is shown in Fig. 3.5* Double reciprocal 
plots yielded straight lines and a spectral binding constant (Ks)
- k .of 7.1 x 10 M was obtained. This agrees well with a Ks value of
6.0 x 10  ^M obtained at 10°.
On repeated scanning of the type I difference spectrum of CCl^F 
or CCl^ in the presence of an NADPH generating system the characteristic; 
spectrum gradually disappeared,,and after 5 min. a new peak in the lf50 nm 
region was observed (Fig. 3.6.a and b). The loss of the type I binding 
spectrum was faster for CCl^ than for CCl^F. In the case of CCl^ a new
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spectral peak formed with a maximum at b ^ b nm. This peak resembled 
the characteristic spectrum of the reduced cytochrome P-^50 substrate- 
complex (see 2.3.2.), rather than the interaction of cytochrome P-l+50 
with carbon monoxide. It is difficult to determine whether the CCl^F 
peak with a maximum at b 50~ b ^2 nm also represented the reduced 
cytochrome P-l+50 " substrate complex. However the magnitude of this 
peak was much larger in the case of CCl^F than CCl^, which is in 
agreement with results obtained for the CCl^F-reduced cytochrome P-I45O 
complex reported in 2.3.2. The characteristic hexobarbitone type I 
difference spectrum disappeared very slowly on NADPH addition and a 
spectral peak with a maximum at b$0 nm was formed .
In all cases the spectral peaks formed in the region of ^50 nm 
reached a maximum and then reduced rapidly in size. The CCl^F peak 
reduced to a stable value at half the maximum value. In the case of 
CCl^ a spectral trough at b^O nm was formed, and the spectral peak
due to hexobarbitone disappeared completely.
3-3.2. Spectral intermediate at M o  nm
On the addition of CCl^F or CCl^ to NADPH-reduced microsomes from 
rats pretreated with sodium phenobarbitone a difference spectrum was 
formed within 30 secs which when compared to the spectrum for cytochrome 
b_, showed an absorption in the ^0-4^5 nm region. In most cases a
p
concomitant reduction in the magnitude of the spectral peak and trough
of the cytochrome b,_ spectrum at b26 nm and ^10 nm was also
measured (Fig. 3-T)- However, in some cases an increase in the magnitude
of the cytochrome bc spectrum was observed* On repeated scanning of the
p
spectrum the shoulder in the 1440-4^5 nm region reduced slightly and a
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steady increase in the magnitude.of the cytochrome spectrum 
was recorded. After a short period a spectral peak in the k^O nm 
region was observed which increased with time. A maximum absorption 
value was obtained after 10 - 15 min. In the case of CCl^ and 
hexobarbitone the peak then decreased in magnitude. A large increase 
in the magnitude of the cytochrome b spectrum paralleled the formation 
of this peak.
The ^ 0  nm spectral intermediate of hexobarbitone is well documented
and was used here as a positive control. This compound showed very
similar interactions to those of CCl^F and CCl^, but the shoulder
at k k 0 - k k 5 nm and the reduction in the cytochrome be spectrum on
(Rj.3.7c)
substrate addition were more marked/. The spectral changes observed 
here are typical for the formation of the ^ 0  nm spectral intermediate 
described by Estabrook et_ al* (1971)•
3.3.3. Substrate-induced oxygen uptake
The addition of CCl^F to microsomal preparations from phenobarbitone 
induced rats containing an NADPH generating system increased the rate 
of oxygen consumption (Fig. 3.8a). In the absence of NADP no oxygen 
consumption was measured, which indicates that no oxygen consuming 
reactions take place when this cofactor is omitted. The solvent 
dimethylformamide was shown to have no effect on the rate of oxygen 
uptake. On increasing the substrate concentration a concomitant increase 
in the rate of substrate-induced oxygen consumption was measured. 
Lineweaver-Burk plots of the reciprocal of the substrate-induced oxygen 
consumption against the reciprocal of the substrate concentration 
yielded straight lines (Fig. 3.9.)*
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Similar results were obtained for CCl^ and hexobarbitone 
(Figs. 10a and b). Table 3.1. shows the Km and \ ax values obtained 
using these substrates.
Increasing the concentration of microsomal protein increased the 
endogenous rate of oxygen consumption and also increased the CCl^F-induced 
rate. A proportional increase in the substrate-induced rate of oxygen 
uptake with increasing protein concentration was observed (Fig. 3.9).
The endogenous rate of oxygen uptake in the rabbit was much slower 
than in the rat (Table 3.1.). However, the addition of CCl^F caused 
a larger increase in the rate of oxygen uptake in the rabbit (Figs.3.8a and b).
3.3.^. Substrate induced NADPH oxidation
On the addition of CCl^F to a rat liver microsomal preparation, from 
animals pretreated with sodium phenobarbitone, the rate of NADPH oxidation 
compared with the rate in the absence of added substrate was increased 
(Fig. 3.11a). Dimethylformamide was shown to have no effect on the rate 
of NADPH oxidation.
On increasing the substrate concentration a-concomitant increase in
the rate of NADPH oxidation was recorded. Lineweaver-Burk plots
yielded straight lines (Fig. 3.12). The Km value obtained, Table 3.2.,
compares well with the Km value obtained for oxygen uptake (Table 3.1.).
Comparison of the V values shows that the stoichiometry of NADPH to
max
oxygen is 1.13 : 1 (Tables 3.1. and 3.2.). Km and Vmax values f6r the 
hexobarbitone induced NADPH oxidation are also shown in Table 3.2.
Comparison of this Vmax value with that obtained for oxygen uptake shows 
the cofactor requirement for this reaction to be 1*12 molecules of NADPH
Fi
g.
* 
3.
10
. 
Li
ne
we
av
er
-B
ur
k 
pl
ot
s 
fo
r 
CC
1-
 
an
d 
he
xo
ba
rb
it
 
on
e 
-i
nd
uc
ed
 
ox
yg
en
 
up
ta
ke
CM
o
o
^ (sq.xun aapjooaa)^ (^q-ToopaA t13!!!11!)
'CM
VD
c3 i—I O O
CM
(sq-iun .zapjooay) (jCq.xooxaA TBiq.iui) tM
Hi
rHI
CJcoo
0>+3ctf
!h
-PW
CO
Mi
cr
os
om
al
 
pr
ot
ei
n 
co
ne
 
1 
mg
/m
l
Ta
bl
e 
3.
1.
 
Su
mm
ar
y 
of 
ki
ne
ti
c 
da
ta
 
fo
r 
su
bs
tr
at
e-
in
du
ce
d 
ox
yg
en
 
co
ns
um
pt
io
n
d
•H
!>s 0
■P -p
•H o
O d
o ft
rH
0  bO rH
> ■  a •vo
H  d ■ rH
Cd *H
•h  a
-p ^
•H 0
a h
H  oa
a
00
vo OJ
OJ
a
•H
0
-P
o
dft
bD
43
cda d•H
0
rH
Oa
a
OJ
r—I 
rH
VO
OJ
rH
t1 -3-1 11
0
1
O
1
O
H 1—1 rH
* * «
LTV co OJ
• • •
CO 00 00
rd
0O
0
+3 0 §
cd •P d
0 d cd • H
•p
■d
d 1
cd 0
d 0 rd d
y 0 0m d y •pd T* d •H
O a fd
d •H d d
0 1 •H cd 0
bD ft 1 rQ -p
O 00 -cf O cd
fd rH rH M d
d O O 0
ft O O rd
■d O
d O
s 01110 sojoxui 
J9ATT peonptit
0110 q,xq juqottsiqcj
ssuiosojoxm
JC0AXT
q.xqq'Bjc p0onpux 
euoq.xqj'Bqouoqd
Fl
fi
.-
3.
11
. 
Me
as
ur
em
en
t 
of 
C
C
l
i
n
d
u
c
e
d
 
NA
DP
H 
ox
id
at
io
n 
in 
li
ve
r 
mi
cr
os
om
al
 
pr
ep
ar
at
io
ns
 
fr
om
Mi
cr
os
om
al
 
pr
ot
ei
n 
co
ne
 
. 
0.
5 
mg
/m
l.
Fi
g.
 
3.
12
. 
Li
ne
we
av
er
-B
ur
k 
pl
o~
b 
fo
r 
fy
ic
hl
or
of
fu
or
on
ie
fh
ar
ie
**
 i
nd
uc
ed
 
NA
DP
H 
ox
id
at
io
n 
in 
th
e 
ab
se
nc
e 
an
d 
pr
es
en
ce
of 
0
.
3
'pi
M 
me
ty
ra
po
ne
CN
CO
UU
CO
CN
CN
CN
[ | _ ujuj -s^jun ja p jo D o ^ j jen.iuj
Ta
bl
e 
3.
2.
 
Su
mm
ar
y 
of 
ki
ne
ti
c 
da
ta
 
fo
r 
su
bs
tr
at
e-
in
du
ce
d 
NA
DP
H 
ox
id
at
io
n
d
•H
0
-P
O
0  d
-P  f t
cd
d  bOa LfN
H  \ •
cd d -3"
•H  •H OJ
-p  a
• H  ^
d  0
H  H
Oa
d
-ct-
ON CO 
i—I
d
•H
0
-PO
dft
bD
a^
d•H
a
LON
OJ CO
Io
rH
M
On
OJ
-4"IO
rH
*
CO
H
0
+3
0
Id
d
1 0
cd »d 0 -p
d 0 d cd
o o d
w d -p
d -d •H nd
O d 0
d •H d CJ
0 1 cd d
bD F=h rQ nd
O 00 o d
nd H X •H
&
O
O
0
m
<D
-pcd
d
w0o
d0)bOO
0w
t>»
'd 2 
cd g
% H fd
d  f t  
•H 00 
rH (D O 
-P O  
cd 
P i
s s u ro s o jo ttu
.10 AT I  Q.BJ: p a o t ip u i  
suoq.tq^uqottapd
S0UIOSO,X0TtII .I0ATT
q x q q u j: p 0o n p u i  
©uoqtqjfBqouaqd
per molecule of oxygen.
In the absence of added substrate the endogenous requirement for 
NADPH and oxygen in the rat was found to be in the ratio 1.52 : 1 
(Tables 3.1. and 3.2.).
In microsomal preparations from rats which did not receive phenobarbitone 
no increase in the rate of NADPH oxidation was measured on the addition of 
CCl^F. The endogenous rate of NADPH oxidation was Ql% lower in control 
animals. The concentration of cytochrome P-^50 in control animals was 
0.59 n moles/mg protein compared with 1. 57 n moles/mg protein in phenobarbitone 
pretreated animals.
A significant increase in the rate of NADPH oxidation was recorded 
on the addition of CCl^F to phenobarbitone-induced rabbit liver microsomal 
preparations (Table 3.2.). Comparison of this value with that obtained 
for oxygen uptake showed the cofactor requirement to be ‘in the ratio of 
1 : 1.19j NADPH to oxygen.'
The stoichiometry for the endogenous cofactor requirement in the 
rabbit was 1.5 : 1, NADPH to oxygen (Tables 3.1. and 3.2.).
3.3.5. The effect of various compounds on the rate of oxygen uptake and 
NADPH oxidation
Tables 3.3a and b summarise the results obtained. The addition of 
0.3 mM metyrapone to phenobaritone-induced rat liver microsomal 
incubations inhibited the endogenous rate of oxygen uptake and NADPH 
oxidation to a similar extent, and was an effective inhibitor of the CCl^F 
increased cofactor requirement. A Lineweaver-Burk plot for the CCl^F 
induced NADPH oxidation showed the inhibition to be competitive (Fig.3.12).
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Carbon monoxide was also a very effective inhibitor. A 30 : JO 
carbon monoxide : oxygen mixture totally inhibited the substrate- 
induced NADPH oxidation in phenobarbitone-induced rat liver microsomal 
preparations. ,In phenobarbitone induced rabbit liver microsomal 
preparations both the substrate-induced oxygen uptake and NADPH oxidation 
were’ completely inhibited by a carbon monoxide oxygen gas mixture 
(80 : 20). Carbon monoxide was shown to have only a slight inhibitory 
effect on the endogenous cofactor utilisation.
Only high concentrations of cyanide showed any inhibitory effect in 
rat liver microsomal preparations, and even in this case the inhibition 
was relatively small. No CCl^F-induced increase in cofactor requirement 
could be measured when NADH was used instead of NADPH.
The addition of catalase to rabbit microsomal preparations showed 
a slight inhibition of the substrate-induced rates compared with controls 9 
yet a large increase in the endogenous rate of NADPH oxidation was 
measured. The CCl^F-induced rates of NADPH oxidation and oxygen 
utilisation in this case were 15.5 n mole/min/mg protein and 18.9 n 
mole/min/mg protein respectively, i.e. 1 molecule of NADPH per 1.22 
molecules of oxygen.
3.3.6. Lipid peroxidation results
The lipid peroxidation experiments in phenobarbitone induce rabbit 
liver microsomal preparations are summarised below:
Malondialdehyde formed (n mole/min/mg protein)
+ NADPH. + NADPH + CC1_F. + NADPH + CC1, „
3 4
No ethylenediaminetetra-
acetic acid 0.24 0.19 0.42
+ ethylenediaminetetra-
acetic acid 0.00 0.19 0.54
CCl^ used here as a positive control caused significant increases in 
malondialdehyde formation. Ethylenediaminetetraacetic acid inhibited 
the endogenous production of malondialdehyde but did not inhibit its 
formation in the presence of CCl^F.
3.4. Discussion
It has been reported by Uehleke (personal communication) that the
14 . o
incubation of CCl^ m  liver microsomes for 30 nun at 37 in open
cuvettes resulted in J0% loss of radioactivity by evaporation. In
spite of the high volality of CCl^F it binds as effectively to the
type I site of cytochrome P-450 at 37° as at 10°. This is probably
due to the retention of CCl^F in microsomal lipid and suggests that
the Ks values obtained are a measurement of the equilibrium between the
CCl^F bound to cytochrome P-450 and the CCl^F dissolved in the lipid.
Because of the very low solubility of this compound in aqueous media,
loss from the aqueous region due to evaporation at 37° will have little
effect on this equilibrium. The rate of formation of the type I binding
spectrum is extremely rapid. Using rapid mixing techniques Estabrook
et_ al. (1972) have shown that the type I spectrum of hexobarbitone
forms in 40 m.secs. The critical process in the formation of the CCl^P
type I spectrum is therefore the amount of CCl^F that is dissolved 
in the microsomal lipid on shaking the cuvette immediately after 
CCl^F addition. It would appear that the distribution of CCl^F 
in the microsomal suspension is not affected extensively whether 
the microsomes are at a temperature above or below the boiling point.
The significance of such parameters as Km and Ks in heterogeneous
systems, such as microsomal suspensions, is always questionable, and
it is possible that they simply reflect the solubility of a particular
compound in the lipid and not the affinity of the enzyme for a particular
substrate. Al-Gailany et al. (1975) have shown a relationship between Ks
or Km values and lipid solubility for a series of substituted anisoles.
The finding that the type I binding spectrum of CCl^F at 37° is stable
and is dependent on the substrate concentration made it possible to
measure substrate-induced oxygen consumption and NADPH oxidation at 37°,
and to obtain apparent Km and Y values.'
max
The difference absorption at nm exhibited by hexobarbitone, a
substrate of the hepatic mixed function oxidase system, requires the presence: 
of oxygen and NADPH (Estabrook et al., 1971; Hildebrandt & Estabrook, 1971). 
CCl^F and CCl^ produce a similar 1+1*0 nm absorption to that exhibited by 
hexobarbitone which suggests that these compounds also interact with oxygen 
and NADPH-reduced cytochrome P-l+50 to form an oxygen: substrate: 
cytochrome P-l+50 intermediate. Estabrook et al. (1972) proposed that this 
spectral absorption represents the formation of an intermediate which is a 
stage in the cytochrome P-l+50 cycle (Fig. 1.1.), before dissociation to give 
oxidised substrate and oxidised cytochrome P-i+50. This proposal is supported 
by the work of Illing et_ al. (I97M .
The formation of this complex by CCl^F indicates that this compound may 
well be metabolised oxidatively by liver microsomes.
It is possible that these spectra represent the binding of a side product
of drug metabolism, such as H202, cytochrome P-^50. However there are no
literature reports which refer to such interactions.
The role of cytochrome b^_ in the microsomal mixed function oxidase 
mediated metabolism of drugs is still unclear. However the initial changes in 
the magnitude of the cytochrome b^ spectrum on substrate addition could be 
explained by its role as an electron donor to the oxygenated intermediate of
cytochrome P-^50.
Oxygen electrode measurements for the metabolism of hexobarbitone show 
that after about ten minutes the microsomal preparation becomes anaerobic.
The degradation of haem proteins in the presence of NADPH to carbon monoxide 
has been reported by Nishibayashi et_ al. (1968). It was therefore suggested 
by Estabrook et_ al. (1972) that the Soret maximum produced in the t50 nm region
after about 10 min of incubation in the presence of NADPH and hexobarbitone 
was due to the formation of the cytochrome P-I50 carbon monoxide complex.
The formation of this complex could account for the spectral absorption in 
the region of -^50 nm observed for CCl^F and CCl^ in investigations into the 
formation of the intermediate absorbing at nm. It is however possible
that in these cases the spectrum represents a combination of the carbon mon­
oxide - cytochrome P-^50 complex and the complex exhibited by these compounds
themselves with reduced cytochrome P-^50 under anaerobic conditions ( s e e
2.3.2.). This possibility is confirmed by the formation of a spectral
peak at h^k nm and not H50 nm when CCl^ is incubated in the presence
of an NADPH generating system (Fig. 3.6b.). The reduction in the
spectral peak at 1+50 nm observed in the case of CCl^ and hexobarbitone
is intriguing as in the experiments to determine the formation of the
spectral intermediate absorbing at nm the reference cuvettes did
not contain an NADPH generating system, and so the final reduction in
this peak can not be accounted for by a negative absorption due to the
formation of a cytochrome P-t^O - carbon monoxide complex in the
reference cuvette. The exact nature of this peak is unclear and
requires further investigation.
On repeated scanning of the type I binding spectrum of CCl^F on the 
addition of an NADPH generating system to the test and reference cuvettes 
the peak at V50 run was formed in 5-10 min and occurred when the test 
cell became anaerobic. Oxygen electrode measurements showed that 
incubation of an,NADPH generating system in the absence of added substrat 
15_20 min were required before anaerobiosis. These experiments gave 
first indications that CCl^F increased the rate of oxygen uptake in rat 
livermicrosomes in the presence of NADPH.
The addition of CCl^F to phenobarbitone-induced rat or rabbit 
liver microsomal preparations increased the rate of oxygen uptake and 
NADPH oxidation. The requirement for NADPH in the CCl^F-mediated oxygen 
uptake and the ineffectiveness of NADH as a replacement indicated the 
involvement of the microsomal mixed function oxidase system. The 
increased cofactor requirement followed classical enzyme kinetics 
and was found to .be dependent on the concentration of microsomal 
protein. Lineweaver-Burk plots in experiments with rat liver microsomal 
preparations gave Km values for oxygen uptake and NADPH oxidation which 
compared well. Comparison of the V values showed that 1 molecule
Iu£lX
of NADPH is required per molecule of oxygen. Experiments with rabbit 
liver microsomal preparations confirmed the results obtained with the 
rat.
The factors contributing to the endogenous rates are unclear 
but could be a combination of several reactions, for example, lipid 
peroxidation (Wills, 1969a; 1969b), and the metabolism of* endogenous 
substrates. The very small inhibition of the endogenous rate by 
carbon monoxide,(Tables 3.3a and b) would indicate that this rate is only 
partially due to cytochrome P-t50 mediated reactions.
The CCl^F mediated increase in cofactor utilisation in rabbit
liver microsomal preparations was also 1 molecule of NADPH per 1.19 
molecules of oxygen. It is well documented that compounds metabolised 
by the cytochrome ~P-k50 mediated mixed function oxidase system have 
an oxygen : NADPH requirement of 1 : 1 (Netter & Kahl, 1969;
Jeffery & Mannering, 197^; Cooper et al., 1963). Hexobarbitone used 
as a positive control here also gave a stoichiometry of 1 : 1.
It is known that some compounds which interact with cytochrome 
P-U50 give a type I binding spectrum and yet are not metabolised 
(Staudt et al., 197^ - )• These workers have also shown that such compounds 
increase the rate of oxygen uptake and NADPH oxidation in liver microsomes. 
However in these cases the increase in NADPH oxidation and oxygen 
consumption was in the ratio of 2 : 1. Such compounds are termed 
’uncouplers’ and the products of such an interaction are unchanged 
substrate and water, i.e.
RH + 2NADPH + 2H
.+
> 2H20 + RH + 2NADP
+
CCl^F gives a stoichiometry of 1 : 1 and therefore does not interact 
in this manner.
If CCl^F is metabolised oxidatively the metabolism could follow 
the reaction sequence:
CC1„F
3
> C0Clo or C0C1F
OH
C02 + HC1 + HF
The absence of increased cofactor requirement on CCl^F addition to
microsomal incubations from rats not pretreated with sodium 
phenobarbitone could be explained by the 3~fold increase in cytochrome 
P-^50 measured in induced animals and the much lower levels of mixed 
function oxidase activity in non-induced animals.
Evidence for substrate oxidation based on cofactor requirements 
is complicated by a number of factors: The reports by Hildebrandt .§&. ■2-L.*
(1973 & 197*0 that hydrogen peroxide is produced during the in vitro 
metabolism of mixed function oxidase substrates make it feasible that 
a compound interacts with cytochrome'P-H50 to give rise to hydrogen 
peroxide and yet is not metabolised, 
i.e.
RH + NADPH + H+ + 0g   7 RH + H 0g + NADP+
This reaction would represent another type of uncoupling reaction and 
would result in a stoichiometry of 1 : 1. If CCl^F caused such an 
interaction the addition of catalase to the microsomal incubation 
would break down hydrogen peroxide to oxygen and water,
2H2°2 —  - > 2H2° + °2
and would change the stoichiometry from 1 : 1 to 2 : 1 NADPH to 
oxygen. The addition of catalase did not alter the 1 : 1 cofactor 
stoichiometry due to CCl^F indicating that hydrogen peroxide was not the 
product formed.
Another microsdmal reaction involving NADPH and oxygen is lipid 
peroxidation (Wills; 1969a; 1969b). The addition of CCl^F to rabbit 
liver microsomal incubations containing EDTA in the presence of NADPH 
caused an increase in malondialdehyde formed. A value of 0*19 n moles/ 
min/mg protein was obtained* However this level of lipid peroxidation
cannot b>e considered very significant as it was not higher than 
control values obtained in the absence of ethylenediaminetetra- 
acetic acid. Also the initial velocity value for oxygen consumption 
at the same CCl^F concentration was 22.0 n moles/min/mg protein, it 
is therefore unlikely that 100 molecules of oxygen are required to 
produce 1 molecule of malondialdehyde. Ernster & Nordenbrand 
(1967) reported that 23 molecules of oxygen are required to produced 
one molecule of malondialdehyde, and also that between 3~5 molecules 
of oxygen are Consumed per molecule of NADPH. These values do not 
fit the stoichiometry found here. In view of this it would seem 
unlikely that lipid peroxidation plays a significant role in 
CCl^F-mediated oxygen uptake.
It is interesting to note that in the presence of ethylenediaminetetra' 
acetic acid an increase in CCl^ induced lipid peroxidation was measured 
which is in contradiction to the report by Reiner et al. (1972) who 
reported that CCl^ induced lipid peroxidation was inhibited by the 
presence of ethylenediaminetetraacetic acid.
CC1„F and CC1, show very similar Kin and V values for oxygen 3 k max . 0
consumption in rat liver microsomal preparations. This is interesting 
in view of the differences in their ability to induce lipid peroxidation 
which might be considered to be a measure of the metabolic activation 
of these compounds.
The microsomal enzyme conversion of stearate to oleate (stearate 
desaturase system) requires NADPH or NADH and oxygen (Oshino et al.,
1966).
NADH
NADPH
Taken from Oshino et al. (1971)
Oshino & Sato (1971) have reported that compounds such as phenols 
increase the electron flow through cytochrome b^ _ into this system.
It is therefore possible that CCl^F could cause a similar effect 
and increase the rate of NADPH oxidation and oxygen uptake. However 
this system is mediated by a cyanide sensitive component and can be 
inhibited by concentrations of cyanide much lower than those required 
to inhibit the cytochrome P-t^O mediated drug metabolising system 
(Oshino et al., 1966; Oshino & Sato, 1971)• A cyanide concentration 
of 0.5 mM is sufficient to inhibit the stearate desaturase system but 
at this concentration no inhibitory effect is measured for cytochrome 
P-^ -50 mediated reactions (Gaylor et al., 1970; Correia & Mannering, 
1973). The results in Table 33a show that this concentration caused 
no inhibition of the CCl^F-induced cofactor utilisation and in fact 
a slight increase was measured. Cyanide (h mM) did cause a slight 
inhibition (30$) but this concentration of cyanide is sufficient to 
inhibit cytochrome P-l+50 mediated reactions (Correia & Mannering, 1973). 
No increase in the rate of NADH oxidation was measured on the addition 
of CCl^F to rat liver microsomal incubations. NADH is an alternative 
cofactor for the stearate desaturase system which again indicates 
that CCl^F-induced cofaetor requirement is not a result of its 
interaction with this system.
steroyl
-> flavoprotein 1 CoA
> cyanide /, , , ^ sensitive (
cytochrome b,. --------------  ^ /
5 component ^
oleoyl CoA
flavoprotein 2 + H^O
Metyrapone, a classical inhibitor of mixed function oxidase 
mediated drug oxidation (Netter et_ al., 1967; Netter & Kahl, 1969; 
Liebman, 1969)~was found to be a very effective inhibitor of CCl^F- 
induced oxygen uptake and NADPH oxidation, a 90-100$ inhibition being 
measured. Illing et_ al. (197^) have shown that metyrapone (3 x 10 ^M) 
caused an 80$ inhibition of hexobarbitone-induced oxygen consumption, 
indicating the potency of this inhibitor.for known mixed function 
oxidase substrates. Lineweaver-Burk plots for the CCl^F-induced 
NADPH oxidation in the presence or absence of metyrapone showed the 
inhibition to be competitive (Fig. 3.12,). Metyrapone has been shown 
to inhibit the O-demethylation of p-nitroanisole and the N-demethylation 
of monomethyl-p-nitroaniline competitively (Netter et al,, 1969) and 
also the 110 hydroxylation of steroids (Dominguez & Samuels, 1963;
p
Sanzari & Peron, 1966). However the nature of the competition by 
metyrapone seems to vary and the literature is rather inconsistent.
For example, Hildebrandt (1972) has reported the N-demethylation 
of ethylmorphine to be non-competitive.
Carbon monoxide, another classical inhibitor of cytochrome■ P-^50 
mediated reactions, was shown to inhibit CCl^F-induced NADPH oxidation 
and oxygen uptake completely.
There are therefore strong indications that the CCl^F-increased 
cofactor requirement is mediated by cytochrome P-^50. There are no 
references in the literature to compounds which cause a cytochrome 
P-^50-mediated oxygen uptake or NADPH oxidation with a stoichiometry 
of 1 : 1 which are not known substrates of the microsomal mixed function 
oxidase system. In the absence, of any evidence that uncoupling reactions 
occur it would seem a reasonable conclusion that CCl^F is metabolised 
oxidatively by this system.
Chapter 4
The metabolism of trichlorofluoromethane
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U.l. Introduction
In vitro experiments can give a great deal of information about 
the behaviour of a compound with a particular enzyme system, and in 
drug metabolism studies in particular can indicate the nature of metabolic 
products to be expected in vivo. However in vitro experiments with tissue 
homogenates, subcellular fractions or reconstituted enzyme systems are 
limited by such factors as oxygen supply and subcellular organisation.
As a result there is no guarantee that the same results can be reproduced 
in vivo .
Evidence for the oxidative metabolism of CCl^F in vitro obtained 
in Chapter 3, with a.Vmax value comparable with most mixed function oxidase 
substrates, indicated that in vivo metabolism may well occur. The 
oxidative metabolism of an oral dose of CCl^ (Butler, 1961; Paul & 
Rubinstein, 1963; Seawright & McLean, 1967)9 of halothane (Stier et al., 
1961+; Rehder et al., 1967; Cascorbi et al., 1970)9 and of similar 
halogenated hydrocarbon compounds is well established. In contrast
there are no reports on the in vivo metabolism of an oral dose of
- ' ' *  '
CCl^F. Cox et al. (1971a) have reported that 97$ of an oral dose of 
CCl^F is expired unchanged within 6 h, however the use of an unlabelled 
CCl^F sample in these experiments made it impossible to determine any 
metabolites.
If CCl^F is metabolised oxidatively in vivo then the most probable 
metabolite is carbon dioxide, possibly produced as follows
CC13F — -- > C0C1F -------^ C 0 2 + HF + HC1
CCl^ and CHCl^ have been shown to be metabolised in vivo to carbon 
dioxide (McCollister et al., 1951;Paul & Rubinstein, 1963; Van Dyke .
et al., 1964a). By analogy with the metabolism of CCl^ (Fowler, 1 9 6 9 ) and 
CBrCl^ (Bini et al., 1975) other metabolites could possibly be CHC12F and
c c i2f  -  c c i2f .
. . . l4
One of the major problems m  the determination of C02 resulting
from the metabolism of a compound as volatile as CCl^F is the possible
14 . . .
contamination of CO^ traps with CCl^F expired unchanged. Preliminary
experiments were set up to establish an effective system for the 
extraction of unchanged CCl^F before the extraction of exhaled carbon 
dioxide.
Experiments were carried out to determine the possible metabolites
14 . . . .
of CCl^F m  the expired air, urine and faeces after an oral dose
lli
of CCl^F. The effect of CCl^F on the in vivo metabolism of an oral
111 . 
dose of CCl^ was also investigated.
4.2. Materials and Methods
4.2.1. Materials
14 . . .
CCl^ was bought from the Radiochemical Centre, Amersham, specific
activity 7*03 y Ci/ii mole. The purity of this sample was confirmed by 
radio g-l.c. analysis.
■^CCl^F was obtained from NEN Chemicals Ltd. (Boston U.S.A.) 
dissolved in corn oil. Their specification gave a specific activity of 
5.03 y Ciy(i mole and a radiochemical purity of 99% as determined by radio 
g-l.c. analysis. The sample was analysed before use by g-l.c. using 
the method described in 2.2.7. A chemical purity of 99% and a 
contamination By CCl^ of 1% was found. No other contaminants were 
detected. As these values were within the specifications given the 
sample was used as supplied. However it later became apparent that the
. 1 4contamination of the sample with CCl^ was prohahly higher than‘the
. 1 4  . ' . . . .mass contamination, i.e. the CCl^ had a higher specific activity than the
14 . . .
CCl^F. The following experiments were carried out to determine whether
this was indeed the case:
a) Reverse isotope dilution assay
14
A sample of the ^^^3^ was a^ e<^  2.5 ml of unlabelled CCl^
contained in a 10 ml pear-shaped flask. The radioactive content of 
a sample of this mixture was determined by scintillation counting 
(Packard Tri-Carb, Model 37200). The mixture was then heated until
g-l.c. analysis of samples showed that all the CCl^F had been removed
. . . . . .  -12 rl4 -1
by distillation. The detection limit for CCl^F was 10 g. The CJ
content of the remaining CCl^ was then determined by scintillation counting,
. . . . 14This value gave the proportion of original counts attributable to CCl^.
... . . 14
Determination of the percentage contamination by CCl^ gave a value 
of 13.3%.
b ) Radio g-l.c. analysis
The operating conditions for the g-l.e. were the same as those
. ■ 14
reported m  2.2.7. Radio g-l.c. analysis showed that CCl^ was the
only contaminant confirming the original g-l.c. analysis. The chart
14 14 .recorder peaks representing CCl^ and CCl^F were cut out, weighed
. . 14 d .
and the percentage contamination by CCl^ was calculated to be 13.2/&
(I am grateful to Dr. Teale of the ICI Agricultural Research Division
for use of their radio .g-l.c.).
4.2. Apparatus
The apparatus used was constructed as shown in Fig. 4.1. The 
metabolism cage and supplementary glassware were, obtained from Jencons 
Ltd. (Hemel Hempstead, Herts). A ’Meterate’ gas flow meter was 
attached to a column containing soda lime to remove atmospheric water
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vapour and CO^. This column was connected to the metabolism cage with 
rubber tubing. The outlet of the metabolism cage was attached to a 
series of four Nilox columns followed by four scintered disc traps.
To improve the trapping efficiency of this series of traps the first 
two Nilox columns were immersed in ethylene glycol : water mixture 
(l : 3)V cooled to “5° using a refrigeration coil (model cc 15, Grant 
Instruments Ltd., Cambridge). To prevent icing of the refrigeration 
coil the cooling mixture was stirred slowly with an electric stirrer 
(model S/75/C, Voss Instruments Ltd,, Maldon). All other traps were 
kept at room temperature.
The Nilox columns and the first scintered disc trap contained 
petroleum spirit (b.p. 100-120°) to extract CCl^F (500 ml per 
Nilox column and 150 ml in the scintered disc trap). The remaining 
scintered disc traps contained 100 ml ethanolamine: ethoxyethanol 
(l : If) to collect exhaled 00^. The outlet on the last trap was 
connected to an electric vacuum pump (model Mu 19/26, Charles Austin 
Pumps Ltd. Byfleet). All connections between the traps and that 
between the first trap and the metabolism cage were made with glass 
tubing to reduce the physical adsorption of. CCl^F which occurs when rubber 
tubing is used.
If.2.3. Efficiency of the trapping system for CCl^F
The efficiency of the traps containing petroleum spirit to remove 
CCl^F was determined by injecting Ik. 6 mg (10 y l) of CCl^F onto a watch 
glass in the metabolism cage and drawing air (200 ml/min) through the 
system for 2k h. Samples of each trap were taken at 3» 6 and 2k h.
To prevent cross-contamination by sucking back the trap furthest 
from the vacuum pump was disconnected first. After 2k h the final 
volume of solvent in each trap was measured. Samples were assayed
for CCl^F content by g-l.c., as described in section 2.2.7.» diluting
the samples with petroleum spirit where appropriate. Chloroform 
—6
(10 g/g solvent ) was added to the samples as an internal standard. 
Absolute values for CCl^F content were obtained from peak area measurements 
and an appropriate calibration curve (Fig. 2.3b).
k.2.k. Experiments with ~^CC1^F in vivo
Male Wistar albino rats (230 - 250 g) maintained on a standard
laboratory diet (Spratts Lab. diet 1) were used. The animals were
. . lU . . .
dosed orally with 10yCi of CCl^F contained in 1.3 ml corn oil,
followed immediately by a second dose containing unlabelled
CCl^F dissolved in ethyl oleate (2 ml). Two administrations were used 
llf
to remove CCl^F left m  the syringe from the first dose. The total
dose was 100 mg CCl^F per kg body weight. The rat was placed immediately
in the metabolism cage and air drawn through the apparatus at a rate of
200 ml/min. The animals were allowed food and water ad libitum. The
contents of all traps were changed after 3 and 6 h and the volumes
of petroleum spirit and ethanolamine : ethoxyethanol noted. After 2 k h
the animals were removed and killed, and the volume of urine and weight
of faeces collected during this period noted. All trap samples obtained
at 3, 6, and 2k h were determined immediately after collection for CCl^F
—6content by g-l.c. using chloroform (10 g/g sample) as internal standard. 
Petroleum spirit samples were diluted where appropriate but samples of 
ethanolamine : ethoxyethanol were injected directly or after extraction 
‘of a 2 ml aliquot with 5 nil of petroleum spirit.
i
The.detection of volatile metabolites was attempted by g-l.c. and 
radio g-l.c. analysis by injection of 5 pi aliquots of the undiluted 
petroleum spirit samples from the first three Nilox columns after 3»
6 and 2k h.
Attempts were made to obtain mass-spectra of the compounds present 
in the petroleum spirit traps using the method described in 2.2.8.
4.2.5. Scintillation counting of samples
All samples were stored at 4° in glass-stoppered flasks for a 
maximum period of 24 h before counting. Samples were counted in 
screw-capped scintillation vials using a Packard Tri-Carb scintillation 
counter.
a) Expired air; Aliquots (5 ml) from the traps containing petroleum 
spirit were added directly to 10 ml of a toluene-detergent scintillant.
(One litre of scintillant contained 666 ml toluene, 333 ml detergent,
4 g of 2,5~diphenyloxazole (PPO) and 0.2 g of 1,4-bis [2-(5-phenyloxazolyl)3 
benzene (P0P0P) . Samples were shaken and counted.
Aliquots (8 ml) of the contents of the C0^ traps were mixed directly 
with 10 ml of the toluene-detergent scintillant. In isolated instances 
where a precipitate was formed in the scintillation vial the addition of 
methanol (iml) gave a clear solution.
b) Urine: Aliquots (l ml) of the collected urine were counted in
8 ml of 'Instagel' liquid scintillant (Packard Ltd., Reading).
c) Faeces: Faeces were weighed and emulsified with water in a homogeniser 
(model 15T83j Grant Instruments Ltd. Chesham, Bucks) to give a 20 %
w/v suspension. A sample of this suspension 0.5 ml was added to hyamine 
hydroxide (3 ml) in a .scintillation vial and left overnight at 50°. 
sample was cooled, 100% hydrogen peroxide (0„3ml) added, and the sample 
left for 3 ■ 4 h at room temperature. Neutralizing with cone HC1 
(0.25 ml) gave a clear solution. 'Instagel* (6 ml) was added, the sample 
shaken and counted.
A sample of faeces from untreated rats was taken as a control 
rl4 -i
and a known amount of [_ CJ toluene added. The faeces were treated 
in the same manner as for test animals to determine the loss of activity 
during sample preparation.
The counting efficiency of all samples was determined using
. rlh' n .either an automatic external standard or a [ CJ toluene internal
standard. The following efficiencies were obtained:-
Petroleum spirit samples 81.7$
Ethanolamine:ethoxyethanol 74*4$
Urine 79*6$
Faeces 76.0$
14
To investigate whether the urine contained unchanged CCl^F 
aliquots (4 ml) were extracted with petroleum spirit (5 ml) by 
vigorous shaking. Samples (lml) of both the aqueous and organic layers 
were counted in ’Instagel’ (8 ml)..
. 14
The contamination of the CO^ traps by CCl^F was determined
in a similar manner. A sample (l ml) was mixed with distilled water .
(4 ml) to reduce the solubility of any CCl^F present and the mixture
extracted with petroleum spirt (5 ml). Aliquots (l ml) of both the
aqueous and petroleum spirit layers were mixed with ’Instagel’ (8 ml)
and counted.
4.2.6. Experiments with ^CCl^ and non-radioactive CC1J? in vivo
' . i4 .
In view of the 13.2$ contamination of the CC1„F sample with
14 . . . . 14
CCl^ it was necessary to determine the contribution of CCl^
to the results obtained. Rats were dosed with corn oil (l ml)
14 , . . .
containing 5 y Ci of CCl^ followed by a second dose (2 ml) containing
unlabelled CCl^F. The final dose was 556 yg CCl^/kg body, weight, which
represented the mass contamination of CCl^ in the CCl^F sample. The
dose of CCl^F was the same as in previous experiments i.e. 100 mg/kg
body weight. The experimental procedure was exactly the same as in
14
the experiments using CCl^F.
. . . i4
A further series of experiments were carried out using CCl^
alone. Rats were dosed orally with corn oil (l ml) containing 
14
5 y Ci of CCl^, followed immediately by 2 ml of ethyl oleate. The 
dose was 556 y g CCl^/kg body weight.
In two other experiments a pure sample of non-radioactive CCl^F 
was dosed in ethyl oleate (i ml) at a dose level of 50 mg CCl^F/kg 
body weight. The expired air was then collected for 3 h. Samples 
(5 yl) of the undiluted trap contents after this period were analysed 
by g-l.c.
A control experiment using ethyl oleate alone was also run.
4.3* Results
4.3.1. Efficiency of the trapping system for CCl^F
The distribution of an unlabelled CCl^F sample in the trapping
system after 3, 6 and 24 h is shown in Fig. 4.2. After 3 and 6 h nearly
all the CCl^F was retained in the first trap. With increasing time there was
a tendency for the CCl^F to distribute throughout the trapping system,
but after 24 h only 0.04$ of the CCl^F could be detected in the CO^
traps. Because of the very low contamination of these traps this system
. i4
was adopted for the detection of CO^ after oral administration of
14 ■ ■ ' 
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, 144.3.2. Experiments with -CC1JF m  vivo
Comparison of the distribution of CCl^F in the trapping system,
determined by g-l.c. analysis, -with the distribution of radioactivity,
14
after an oral dose of CCl^F to rats is shown in Figs.4.3a, b, 
and c. These figures represent the results of a typical experiment.
The distribution of radioactivity in the petroleum spirit traps 
followed the distribution of CCl^F very closely, indicating that the 
radioactivity measured in these traps represented "^CCl^ exhaled
unchanged. However radioactivity was also detected in the CO^ trapping
14 . . .
system. In the absence of any CCl^F m  these traps the activity
Ik .could be accounted for by the presence of CO^. Extraction of the 
diluted ethanolamine : ethoxyethanol mixture contained in the CO^ 
traps with petroleum spitit showed all the radioactivity to remain
in the aqueous phase, confirming that the radioactivity was not due
14 . 14 .
to CCl^F. The rate of exhalation of C-labelled material is shown
in Fig. 4.4. After 24 h 95% of the dose was recovered. The biological
half-life of CCl^F in the rat after oral dosing was found to be 4,5 h.
Fig. 4.5. shows the rate of production of ^CO^. After 24 h...10.8#
14 14
of the dose was found to be CO . The rate of C0_ production paralleled
c. f cL
the rate of excretion of total radioactivity.
Analysis of the urine and faeces after 24 h showed 1.4$ of the
dose to be excreted in the urine. This radioactivity was not due to
14 . . . .unchanged CCl^F as an extraction of the urine with petroleum spirit
all the radioactivity remained in the aqueous phase. The faeces 
contained 0.1$ of the dose.
Table 4.1. is a summary of the experiments using the ^CCl^F sample 
showing the routes of excretion of the dose.
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G-l.c. analysis of the undiluted petroleum spirit samples from 
the first three traps after 39 6 and 2l+ h showed the presence of two 
peaks in addition to that of CCl^F. Fig. k.6, shows a typical g-l.c. 
trace. One peak had a very short retention time (1.5 min) and the 
other a retention time of 8.2 min. The retention time of the first 
peak did not coincide with that of CHCl^F. The second peak had a similar 
retention time to that of chloroform. G-l.c. analysis of the petroleum 
spirit traps from experiments where a pure unlabelled CCl^F sample
was dosed to rats showed the presence of both peaks, indicating that
. . . .  . lUthese peaks did inot result from impurities present in the CCl^F
starting material. These peaks were not detected by g-l.c. analysis 
of the radioactive starting material, or in experiments where rats were 
dosed with corn oil only. It would therefore seem likely that these 
peaks represented metabolites of CCl^F. It was not possible to detect 
these peaks by radio-g-l.c. analysis.
The concentration of the peak with the shorter retention time was 
too low to obtain a mass spectrum. The mass spectrum of the second 
peak is shown in Fig. ^.7* The mass ions shown represent ions not 
present in background scans taken immediately before and after the 
detection of the peak on the g-l.c. trace. The mass ions obtained 
are similar to those obtained for CCl^F (Fig. 2.12.) and indicates 
that the metabolite contains fluorine and is therefore not chloroform. 
Since this metabolite had a longer retention time than CCl^F it could 
represent the formation of CCl^F-CCl^F.
As these metabolites were not identified conclusively, absolute 
concentrations could not be determined. However it can be seen that 
they only represented a very small proportion of the dose. To obtain
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approximate information as to the rate of formation of these metabolites 
it was assumed that peak height was proportional to concentration. The 
curves obtained using this approximation are shown in Figs. U.8.a'and b.
The rate of excretion of both metabolites paralleled the rate of exhalation 
of total radioactivity.
1+.3.3. In vivo experiments using ~^CC1^
The dose of CCl^ used in these experiments was the same as that
. i hcalculated to be present as an impurity m  the CCl^F sample.
The distribution of radioactivity through the trapping system
after 3, 6 and 2k h when ^CCl^ was dosed in the presence of unlabelled
CCl^F is shown in Fig. U.9. The majority of the radioactivity was
present in the first Nilox column. The absence of significant
amounts of radioactivity in traps 3, ^ and 5 indicated that no contamination
lUof the CO^ trapping system with CCl^ had occurred. A large amount
of radioactivity was detected in the ethanolamine:ethoxyethanol traps
I kand indicates the presence of CO^.
ll+ . .
When CCl^ was dosed m  the absence of CCl^F a very similar
distribution of radioactivity was obtained. Fig. V.10 compares the
rate of excretion of total radioactivity from the three major series
lU . . ii+ . i^
of experiments i.e. CCl^F containing CCl^ impurity, CCl^ +
ll* .
unlabelled CCl^F, and CCl^ dosed alone. Because of the difference
in the dose it is not possible to make a direct comparison between
Hi il|
the rate of excretion of CCl^F and CCl^. However it can be seen
ill
that m  the presence of CCl^F the rate of CCl^ excretion was faster 
14
than that of CCl^ dosed'alone, the difference being statistically
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Fig. ^.10. Comparison of the rate of excretion of -*^CC1JF + contaminant
I k  Ik 'CCl^ + CCl^F, and CCl^
100
CC10F
CC1
CC1
»—I. I
12
Time (h)
f contaminant 
+ CC13F
Mean values from 3 experiments ± S.E.M.
significant (p < O.OOl) in the first few hours after administration
of the dose. The biological half-lives of CCl^ in these two series
of experiments was 8.5 h and 12 h respectively. After 2 k h 75% 
lUof the CCl^ had been excreted but m  the presence of unlabelled CCl^F 
85% of the radioactivity was excreted.
. llf . . . ,
Comparison of the rates of CO^ production are shown m  Fig. 4.11.
After 2k h, 23.0$ of the ^CCl^ sample was metabolised to ^CO^, a value
36% higher than that obtained in the presence of unlabelled CCl^F (l8.U$).
lU . . . .
This increase m  CO^ production was only statistically significant at
2k h (p < 0.05). In contrast after 3 h significantly less ^CO^ "was 
produced when only ‘^ CCl^ was administered(p < 0.05).
I k . .
Small amounts of the dose of CCl^ were recovered m  the urine
and faeces, 6.8 and 2.2% respectively. In the presence of unlabelled 
CCl^F, the urine contained k . 6 % of the radioactivity due to ^CCl^ and 
the faeces, 1.0$.
Table 2. is a summary of all the in vivo experiments using radiolabelle 
compounds.
k.k. Discussion
. . . . li|.
Interpretation of the m  vivo experiments using the CCl^F sample
supplied by NEN Chemicals Ltd. was complicated by the presence of the
llf . . . .
(?C1^  contaminant. To obtain meaningful results it was therefore
. . lU
necessary to determine the contribution of CCl^ to the results obtained,
Cox (1972) reported that rats dosed orally with CCl^F (50 mg/kg 
body weight) exhaled half the dose after 2,7 h, and Cox et al. (1972a) 
reported that after 6 h 97% of the dose was exhaled unchanged. In
Fig. U.ll. Com-parison of rate of CO^ production from CC1 F + contaminant
Ik Ik
CCl^ + GCl^F. and CCl^.
CC1
CC1, + CC10F
'CCl^F + contaminant
10
Time (h)
Mean values from 3 experiments ± S.E.M.
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experiments here the biological half-life of CCl^F in rats was
4.5 h and after 6 h only 60% of the dose had been recovered. The 
I k  .
rate of CCl^F excretion was found to parallel the rate of
. . .  it .
elimination of CCl^, when dosed m  conjunction with unlabelled
CCl^F (Fig. t.10.). As only 1 3 . 2 % of the total radioactivity in the
it it . it
' CCl^F sample was CCl^ the contribution of CCl^ to ‘the values
obtained would be very small. In fact the rate of CCl^F excretion
as determined by g-l.c. analysis followed the values determined by
radioactivity measurements very closely (Fig. k .3 .) and confirmed
the value of t.5 h obtained for the biological half-life. The rate 
. it
of excretion of the CCl^ sample when dosed alone was found to be 
very similar to values reported in the literature in spite of the 
very low dose level used here (Seawright & McLean, 1967; Paul &
Rubinstein, 1963; Marchand et al., 1970), 73.9% of the dose was found
1 itto be excreted after 2t h. In the presence of CCl^F more 0C1^
was excreted after 3 and 6 h however after 2k h the values were no
longer significantly different (Fig. U.10.;). It is difficult to
account for this effect.
it .
After an oral dose of CCl^F a significant amount of radio-activity
was detected in the carbon dioxide traps. In the absence of any
it
detectable unchanged CCl^F it was concluded that this was due to
the presence of "^CO^, and accounted for 10.8% of the dose. lQ.k%> of 
it
an oral dose of CCl^ m  the presence of unlabelled CCl^F was found -■
It . . it
metabolised to CO^. The contamination of the CCl^F sample by
13.2% ^CCl^ implies that about 2.5% of the dose detected as
. . . . . it .
m  the original experiments was attributable to CCl^. As this is
it .
only a small proportion of the total CO^ produced, it can be concluded.
that about 8% of the ^CCl^F was metabolised to "^COg* The variation 
in values obtained from experiments using the same experimental 
conditions was very small, which supports this assumption.
It is interesting to note that in the absence of CC1 F 23% of
lit . I k
a dose of CCl^ was metabolised to COg. This value is much higher
than the published literature values which are in the region of 1%
(Paul & Rubinstein, 1963; Seawright & McLean, 1967)9 and is probably
a factor of the dose used. The very high dose (1-5 g/kg body weight)
used by these workers is unsuitable for metabolic investigations since
doses as low as 130 mg/kg body weight cause liver damage and thus
impairment of metabolism.
A small but significant decrease (36%) in the amount of "^COg 
1 hproduced from CCl^ after 2k h was found when the rats were dosed 
in conjunction with CCl^F. The inhibition was significant only at
i . . ih
the 24 h time point and in fact after 3 h the rate of COg production
. . . ih .
was significantly greater when CCl^ was dosed m  the presence of
c c i3f .
lit lit .
CCl^F was excreted at a faster rate than CCl^, the biological
half-life for ^CCl^ being 12 h, and for CCl^F, 4.5 h. This suggests
that the liver concentration of CCl^F would also decrease more rapidly
than that of CCl^. Cox (1972) has shown a very rapid decrease in the
concentration of CCl^F in the livers of rats after oral dosing. If
lit . . .
the inhibition of CCl^ metabolism by CCl^F were competitive then this 
effect would be most marked in the first few hours after dosing. This 
was not the case and suggests a more complicated mechanism.
Ill . . . .
When was dosed m  conjunction with CCl^F a reduction in
the non-volatile metabolites detected in thevurine and faeces was
recorded (Table k , 2 .). The radioactivity in the urine was 31$ lower
I k . •than when CCl^ was dosed alone. This value is comparable to the
. . . . .  li+ . ,
inhibition observed m  CO^ production after 2k h. In the presence 
of CCl^F the reduction in radioactivity detected in the faeces was 
5k%. These results may indicate an inhibition of the metabolism of 
^CCl^ by CC13F.
CCl^F was found to be metabolised to non-volatile products which
. . . . . 14were excreted in the urine. Metabolism of contaminating CCl^ could
not account for this level of radioactivity. The nature of these 
metabolites was not determined. There have been reports in the 
literature that metabolites of brominated haloalkanes are excreted 
in the urine as mercapturic acid conjugates (Bray & James, 1958; 
Thompson et_ al<>, 1963). McCollister et al<> (1951) reported that 10 h 
after an inhaled dose of *^CC1^ to monkeys 10.2$ of the radioactivity 
in the urine was urea and 1.3$ was carbonate. CCl^F may give rise 
to the same metabolites.
Since approximately ten times more radioactivity was recovered
. . lUin the faeces of animals receiving CCl^ with unlabelled CCl^F than
. . lU . . . .m  animals receiving CCl^F it is not possible to determine whether
lUthe faecal radioactivity is a result of the metabolism of CCl^F 
li+
or the CC1, contaminant. k
G-l.c. analysis of the contents of the petroleum spirit traps
^ . ilj . . . . • .
3, 6, and 2k h after CCl^F administration indicated the formation
of two volatile metabolites. The administration of pure non-radioactive
CCl^F also gave these peaks, eliminating the possibility that they were
I k
metabolites of the GCl^ contaminant. Although these metabolites should
have been radioactive it was not possible to detect them using radio- 
g-l.c. because of the very small amounts fo'rmed. However mass 
spectral analysis indicated that the metabolite with the longer 
retention time was CCl^F-CC^F. There are reports in the literature 
that CCl^ is metabolised to CHCl^ an<^- C2^^6 (®u^ er» 196l; Fowler,
1969; Bini et al., 1975)9 and also that CBrCl^ is metabolised to 
CHCl^j CHBrCl^, and C^Cl^ (Bini et al., 1975). The other metabolite 
of shorter retention time than CCl^F did not correspond to CHCl^F 
and its nature remains to be determined,
Blake & Mergner(197*0 showed that after inhalation of ^CCl^F,
. Ik
beagle dogs exhaled 0.3% of the dose as CO2 and excreted 0.1%
of the dose in the urine. The interpretation of these results was
. . . ik
complicated, as m  experiments here, by contamination of the CCl^F
lk
with CCl^.
Evidence has been obtained for metabolism of CCl^F after an 
oral dosing to rats. The metabolism could follow the reaction sequence
/
/
CCl^F CCl^F
Cccv;]
CC10F 
/  / 3 x
/ I
I
CC12F
OH
N
CC1F
CO + C1+ F
[COCI or COCIf]
Kubic et al» (197*0 have reported that dichloromethane is metabolised
to carbon monoxide after an oral dose to rats. However, these workers
could not detect carbon monoxide after the administration of CC1, or
k
CCl^F. In spite of this, this possibility is worthy of further 
investigation in the case of CCl^F and CCl^ as it may give an insight 
into the nature of any active intermediates which are formed. CCl^F 
may be metabolised to give formate ions, and formate ions may represent 
a proportion of the radioactivity detected in the urine in experiments 
here. This possibility is supported by the detection of trifluoroacetic 
acid as a urinary metabolite of halothane (Stier et al., 196*0.
The metabolism of CCl^F in vivo is further evidence of the similarity 
of this compound with CCl^. Possible explanations for the differences 
in their toxicities are discussed in Chapter 6.
Chapter 5
. IkIrreversible binding of CCl^F to liver microsomal 
macromolecules in vitro
Contents
5.1. Introduction
5.2. Materials & Methods
5.2.1. Materials
5.2.2. In vitro incubation experiments 
5.3. Results
. I k  . . .
5.3.1. Irreversible binding of CCl^F to liver microsomal proteins
in vitro
lk . .
5*3.2. Irreversible binding of CCl^F to liver microsomal lipids
in vitro .
5.*W Discussion
5.1. Introduction
It has been shown by many workers that some compounds metabolised 
by the hepatic microsomal mixed function oxidase system give rise to 
toxic intermediates (see Parke, 1968). The irreversible binding 
of these intermediates to liver macromolecules has been of great 
interest recently, and has led to suggestions that binding to hepatic 
DNA could be the initiating step in hepatocarcinogenesis (Miller &
Miller, 1966; Miller, 1970; Magee & Barnes, 1967; Weisberger & Weisberger, 
1973).
It has also been proposed that the liver necrosis induced by 
halogenated hydrocarbons results from the binding of reactive intermediates 
to liver proteins and lipids (Reiner et al., 1972; Uehleke et al., 1973a; 
1973b; Uehleke, 197*f) • The binding of halothane metabolites to liver 
proteins has been suggested as the initiating step in the sensitisation 
of the liver to a second dose of halothane resulting in hepatic necrosis 
(see 1.2.).
The work reported in previous chapters indicates that CCl^F is 
metabolised both in microsomal preparations in vitro and in_ v i v o In- vitro 
evidence has been obtained for the metabolism under either aerobic or 
anaerobic conditions. By analogy with CCl^ these findings suggest that 
the intermediate products of CCl^F metabolism may bind irreversibly 
to subcellular macromolecules. In view of the reported absence of 
CCl^F induced hepatotoxicity evidence which indicates that this compound 
binds to liver macromolecules may prove useful in determining the role 
of irreversible binding of active intermediates in halogenated hydrocarbon 
toxicity*
The experiments reported here investigate the possibility of the 
irreversible binding of CCl^F under both aerobic and anaerobic conditions. 
As a result of a report of Uehleke (1973), that the irreversible binding 
of CCl^ to subcellular macromolecules is inhibited by oxygen,emphasis 
was placed on experiments carried out under anaerobic conditions.
5.2. Materials and Methods
5.2.1. Materials
ll+ . . ■ ■ . . . ■ ■  ■
The same sample of CCl^F was used m  these experiments as for those
reported m  Chapter 4. The CCl^F received from NEN Chemicals Ltd. was
dissolved in corn oil, and as such was unsuitable for the determination
of irreversible binding to lipids in vitro. The sample was distilled
into ethanol at room temperature using the apparatus shown in Fig. 5.1.
The bulb containing the solution in corn oil was heated occasionally
with warm water and the distillation allowed to proceed for 12 h. As
reported in 1 3 * 2 % of the radioactivity in the corn oil sample
ll+ , . . Ill
was CCl^. Aftef distillation the contamination of the CCl^F m
Ik M . . '
the ethanol by CCl^ was reduced to less than 3%* After dilution of this
sample with unlabelled CCl^F for the in vitro experiments, the mass
contamination by CCl^ was less than 0.1$.
All other chemicals used were of reagent grade and were obtained from 
the usual commercial sources.
5.2.2. In vitro incubation experiments
Male Thiiringer Gemsen rabbits pretreated with 0.1$ sodium 
phenobarbitone in the drinking water for 12 days were used. Washed 
liver microsomal preparations were prepared according to the method
of Uehleke et al. (1970).
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Protein determinations were made according to the method of 
Lowry et al. (1951) and cytochrome P-H50 was determined hy the method 
of Omura & Sato (l96^a). The cytochrome P-l+50 concentration was
3.5 nmole/mg protein.
The incubation procedure used was that of Uehleke et al. (1973b);
with minor modifications. Atypical incubation experiment for the
. . . . lUdetermination of the irreversible binding of CCl^F to microsomal
proteins and lipids was:- :
Microsomal protein 
Gluco s e-6-pho sphat e 
NADP+
Glucose-6-phosphate dehydrogenase 
MgCl2
CC13F or CCl^
of radioactivity per ml incubate.
5 mg/ml 
12 mM 
0.6 mM 
0.8 units/ml 
9 mM
1 mM containing 0.25UCi
The microsomal preparations were suspended in 0.1 M Krebs-Ringer 
phosphate buffer, pH 7*^ +. The final incubation volume for the 
determination of irreversible binding to proteins was 1.5 ml. 
Incubations were carried out in 2 ml screw-capped vials, closed with 
a Teflon-lined rubber septum. The final incubation volume for the 
determination of irreversible binding to lipids was 5 contained 
in similar vials.
In experiments carried out under anaerobic conditions the buffer 
solution was first saturated with nitrogen, and any remaining oxygen 
removed from the incubation system by successive evacuation and 
flushing with nitrogen, using two needles inserted through the rubber
septum (Fig. '5.2a).'' ^CCl^F (or ^CCl^) in ethanol (9 yl) was then 
injected into the incubation medium through the rubber septum using 
a 10 y 1 g-l.e. syringe. The vials were incubated in a shaking water 
bath at 37° for 60 min.
For the determination of irreversible binding to proteins 
duplicate 100 y 1 aliquots of the incubation medium were withdrawn 
at various time intervals using a 100 \i 1 syringe inserted through; 
the rubber septum. The 100 y 1 aliquots were then applied onto 
filter paper discs (Schleicer & Scholl No. 598, 2.5 cm diameter) 
which had been soaked previously in 5% aqueous trichloroacetic acid 
and dried. The discs were supported on stainless steel pins inserted 
into a polystyrene board (Fig. 5*2 b). After application^the samples
were dried carefully with warm air and transferred to a glass cylinder
fitted with a perforated base (Fig. 5.2 c). To ensure that no 
cross-contamination of samples occurred during the removal of unbound radio- 
activity several blank filter paper discs were also included.
The procedure for washing the discs free o f  unbound radioactivity
and the subsequent scintillation counting of the samples is described
by Uehleke et al. (1973b).;
The irreversible binding of CCl^F to microsomal lipids was 
based on the methods of Folch et al. (1957) and Castro & Diaz Gomez 
(1972). The following procedure was finally adopted. Aliquots (0.5 ml) 
of the incubation mixture were removed at various time intervals and added 
to 9o5 nil chloroform : methanol (2 : l) contained in 15 ml stoppered, 
graduated tubes. The tubes were clamped and shaken vigorously in an 
electric shaker for 5 Min and 9*5 Ml of the contents were removed and 
made up to 10 ml with chloroform ; methanol (2 : l). Distilled water 
(2 ml) was added, the mixture shaken vigorously for a further 5 min,
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and then centrifuged for 10 min (2000 r.p.m.). The upper aqueous 
phase was discarded.and the chloroform : methanol phase washed 
twice by the addition of 0.5 ml of chloroform : methanol (2:1) 
containing 20 ml of water per 100 ml of solution, discarding the upper
aqueous phase after each extraction. A sample (6 ml) of the
remaining solution was pipetted into tared scintillation vials and
evaporated to dryness at 10° under a stream of nitrogen. To ensure
1^ 1 ' . complete removal of unbound CCl^F a few drops of non-radioactive
CCl^F were added and the vials heated to constant weight. The weight
of lipid was noted, T ml of scintillant added,and the samples counted.
The counting efficiency determined using an automatic external
standard was Q0%.
The irreversible binding of CCl^F to microsomal proteins and lipids 
was investigated under the following conditions:
1) aerobic,
2) anaerobic,
. 3) aerobic and anaerobic in the absence of NADPH (NADP was omitted
from the generating system),
if) in the presence of 1 mM metyrapone (injected into the anaerobic 
incubation medium as an emulsion in water immediately prior to the 
addition of substrate),
5) in the presence of carbon monoxide(bubbled for 30 s through 
the anaerobic incubation medium prior to the addition of substrate).
5.3. Results
. . lif .
5.3.1. Irreversible binding of CCl^F liver to microsomal proteins
in vitro
The results obtained from these experiments are shown in Fig. 5.3.
No radioactivity was detected on the blank filter paper discs added 
to the test samples immediately prior to the washing procedure which 
indicates that no cross-contamination occurred during this procedure.
In the absence of NADPH, incubations under either aerobic or anaerobic 
conditions showed an insignificant incorporation of radioactivity into 
microsomal proteins. In the presence of NADPH and air the amount of 
binding was time dependent, maximum binding being obtained after about 
30 min. The initial rate of binding in the presence of either air 
or nitrogen was the same, i.e. 1.7 nmole/min/mg protein with a 
■^CCl^F concentration of 1 mM. Under these conditions 50$ of the 
maximum value for binding was obtained within the first five minutes 
of incubation. The. maximum binding was slightly higher in the presence 
of air compared with nitrogen but the difference was not statistically 
significant.
Metyrapone (l mM) or carbon monoxide caused a marked reduction in 
the initial rate of binding; metyrapone gave 0.3 nmole/min/mg protein, 
and carbon monoxide, 0.0^3 nmole/min/mg protein. After 60 min incubation 
in the presence of metyrapone a maximum incorporation of radioactivity 
had still not been obtained.
ll
In anaerobic experiments with CCl^ the amount of radioactivity
ll
bound after 60 min was approximately twice that obtained with CCl^F; 
^CCl^F gave a maximum value of 7.5 n mole /mg protein compared with 
a value of 15.1 nmole/mg protein for ^CCl^.
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5.3*2. Irreversible binding of CC1JT to liver microsomal lipids 
in vitro
The results of these experiments are shown in Fig. 5.^«
The results bear many similarities to those obtained in the 
determination of binding to microsomal proteins. No radioactivity 
could be detected in the lipids from incubations in the absence of 
NADPH. In the presence of NADPH a time dependent incorporation 
•was observed. In aerobic incubations the initial rate of binding 
■was slower than that obtained in the presence of nitrogen values of 
2.1 n mole/min/mg lipid and 5.0 n mole/min/mg lipid were obtained 
respectively. In both cases maximum binding occurred after 20-30 min,
50% of the maximum value being achieved within 5 min. After 60 min 
incubation less radioactivity was found in the fractions incubated 
inJthe presence of air than those under nitrogen.
Both metyrapone and carbon monoxide inhibited the incorporation 
of radioactivity into microsomal lipid; the initial rates of incorporation 
were l , k and 0.26 n mole/min/mg lipid respectively. In the presence 
of 1 mM metyrapone 50% of the maximum value was obtained after 20 min, 
while in the presence of carbon monoxide the rate of incorporation 
of radioactivity was linear over the entire incubation period.
t 1
A summary of the results of experiments on the incorporation
1^ . . . .
of CCl^F into microsomal: lipids and proteins is shown m  Table 5*1*
OJ
on
oo
oo
oo
pxdxx Sui/ jI TOO 9T0UI
Table 5.1. Incorporation of radioactivity from CC1JF into microsomal 
proteins and lipids after in vitro incubation.
n
Initial Rate 
mole/min/mg
. . . .% of maximum initial
rate of incorporation
Binding after 60 min 
n mole/mg
Protein binding
k2 ; 1.73 100 7.6
Air 1.73 100 8.9
metyrapone 
(jinder N^) 0.3 17.3 6.5
CO
(under 0.0^3 2o5 2.5
Lipid binding
n2 5.0 100 32.5
Air 2.1 k2 26.0
metyrapone 
(under ) l . k 28 29.5
CO
funder N^) 0.26 5.2 16.1
*
The maximum initial rate of binding was that obtained under 
which is taken as 100$
5-H. Discussion
The problems encountered in the in vivo experiments (Chapter 10,
. . lH . lh.
due to the contamination of the CCl^F sample with OCl^, were overcome
. . . . . . i4
m  this series of experiments by the distillation of the CCl^F into
• 14- . : .■ethanol. CCl^F binds irreversibly to the proteins and lipids of 
rabbit liver microsomes in vitro. The term "irreversibly" is used 
here because there is no direct evidence that covalent bonds are 
formed, but it is difficult to imagine any other bonding which would 
remain intact during the rigorous precipitation and extraction procedures. 
Indeed many workers have adopted the; use of the term"covalent binding" 
to describe experiments using similar techniques.
NADPH is a necessary cofactor for the irreversible binding of
ll+ . . . . .
CCl^F to both lipids and proteins, which suggests that metabolism
by the mixed function oxidase system is required before binding takes
place. Uehleke et al. (1973a) reported that the irreversible binding
ll+ . . . . . . .
of CClj^  to rabbit liver microsomal proteins under aerobic conditions
was 60% lower than under anaerobic conditions. It is therefore •
' IV ' . . . .interesting that CCl^F binds as effectively to proteins m  the presence
of air as in the presence of nitrogen. These findings suggest that the 
metabolic activation of CCl^F is equally effective under either of these 
conditions. The difference between CCl^ and CCl^F could be explained 
in one of three ways;
1) The metabolic activation of CCl^ is inhibited by oxygen whereas 
that of CCl^F is not.
2) The active metabolic intermediates derived from CCl^ are more 
readily oxidised than those derived from CCl^F,
3) CCl^ is known to cause the degradation of cytochrome 50 
under aerobic conditions (Reiner et_ al., 1972). If this enzyme is
involved in activation of CCl^, a reduction in the irreversible 
binding to proteins under aerobic conditions could be explained by 
a reduction in the amount of active metabolite produced. However, 
this effect is not sufficiently rapid to account for the inhibition 
reported. ,
Of these possibilities the second would appear to be the most 
likely.
The fact that active metabolites of CC1_F bind to proteins and
3
lipids , when incubated Under aerobic conditions in the presence of 
NADPH, gives further evidence for the oxidative metabolism of CCl^F 
in vitro reported in Chapter 3.
Many of the halogenated alkanes have been reported to bind 
irreversibly to microsomal proteins and lipids. The results of some 
binding experiments carried out in the same laboratory as those 
reported here, using the same experimental conditions, are compared 
in Table 5•2. Werner & Uehleke (197^0 showed that, as with CCl^F, 
the initial rate of binding of CHCl^ and CCl^ was very rapid, 50$ 
of the maximum value being obtained within the first 5“10 min of 
incubation. The incorporation of halothane was much slower and 
approximately 30 min of incubation were required before 50$ of maximum 
binding was obtained. CCl^-induced degradative reactions such as 
lipid peroxidation require the presence of oxygen. It is noteworthy 
that under these conditions more ^CCl^F than "^CCl^ was bound to microsomal 
proteins. Furthermore» CHCl^, which is known to cause liver necrosis, 
binds less effectively than CCl^F to both lipids and proteins.
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Ilett et al. (1973) reported that the toxicity of CHCl^ was related
to the irreversible binding to tissue macromolecules.
ll). ... . . . .
The incorporation of CCl^F into lipids and proteins was inhibited
by either metyrapone or carbon monoxide. These results indicate the
involvement of the hepatic microsomal mixed function oxidase system in 
the activation process, and in particular the involvement of cytochrome 
P-U50. Table 5*3. compares the inhibition of CCl^F binding to microsomal 
proteins with published results for CCl^ and halothane. All the results 
shown were carried out under similar experimental conditions. The 
percentage inhibition by carbon monoxide was similar for all three 
compounds and suggests a similar activation process. The involvement 
of cytochrome P-U5O in the in vivo binding of CCl^ to microsomal lipids 
and proteins has been demonstrated by D*Acosta et al. (1972; 1973).
Experiments in vitro have been of major importance in the study 
of binding to tissue macromolecules (see Gillette, 197^)* Compounds 
which bind in vitro have often been found to bind in vivo. The majority 
of such reports for the halogenoalkanes in vivo are concerned with the 
binding of an oral or an intraperitoneal dose to macromolecules in: 
laboratory animals a Halothane, CCl^ and CHCl^ have all been shown to 
bind to liver lipids and proteins in vivo (Van Dyke & Gandolfi, 197^ -; 
Werner & Uehleke, 197^; Reynolds, 1967; Rao & Recknagel, 1969;
Gordis, 1969; Rocchi et al., 1973; Castro et al.(1973a) Ilett et al.,
ill
1973). It has been shown that the binding of CCl^ to liver 
microsomal lipids in vivo occurs rapidly and is apparent within the 
first 5 min of administration of an oral dose to rats (Rao & Recknagel, 
1969)* The majority of binding occurs with the phospholipid fractions 
(Gordis, 1969; Villaruel & Castro, 1973). The results of in vitro 
experiments carried out here suggest that irreversible; binding of CCl^F 
metabolites to liver macromolecules in vivo may well occur.
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Chapter 6
Final Discussion
Contents
6.1. Introduction
6.2. Discussion of Results
6.3. Potential toxicity of CCl^F
6.k, Contribution of this work to theories concerning halogenated 
hydrocarbon hepatotoxicity
6.1. , Introduction
The work reported in this thesis provides evidence for the 
metabolism of trichlorofluoromethane both in vitro and in vivo. The 
results obtained have already been discussed with respect to relevant 
published work at the end of each chapter. This final discussion 
attempts to co-ordinate all the results obtained, to consider the 
potential toxicity of CCl^F, and to determine whether the results 
contribute to established theories of halogenoalkane toxicity.
6.2; Discussion of results
A summary of the possible intermediates involved in the metabolism 
of CCl^F are shown below:-
cci3f
i
ticytochrome " 
; P-if50
c h c i2f
-[c c i2f,  .T
and/or
c c i2f
CC1 f -Cl
C0C1F or C0C1
s/
[c C IF : ]
+2H2-
CO +HC1 +HF
C02 + HC1 + HF
+ HF + HC1
Fig. 6.1.
The results of experiments in vitro have indicated the involvement 
of the hepatic microsomal mixed function oxidase system, and in 
particular cytochrome P-^50, in the metabolism of CCl^F. There is 
evidence that in the presence of oxygen the formation of an oxidised 
metabolite of CCl^F -will occur preferentially to the formation of the 
carbanion, CCl^F (see later). This possibility -would explain the 
inhibition by oxygen of the formation of CHCl^F reported in 2.3.3. The 
question also arises whether the same site on the cytochrome P-lj-50 
molecule .is responsible for the formation of both the oxidised and 
reduced metabolites. Evidence exists which indicates that the same 
site is responsible for the anaerobic dechlorination of CCl^F and the 
NADPH-dependent formation of the k$2 nm complex with reduced cytochrome 
P-l+50 under anaerobic conditions;
1) both processes require anaerobiosis,
2) the apparent Km values are very similar, 1.9 mM and 1.2 mil 
respectively,
3) the rates of formation of reduced metabolite and the NADPH- 
reduced cytochrome P-J+50 complex are similar, maximum metabolite or 
complex formation occurring after 15 ~ 20 min of incubation.
. Mansuy et al. (197*0 have provided evidence for the formation 
of carbene complexes with reduced cytochrome P-U50. Such an 
intermediate is compatible with the proposed intermediates for the 
metabolism of CCl^F (Fig. 6.1.).
In the presence of oxygen CCl^F exhibits a type I binding 
■ ' -k
spectrum with a Ks value of 7*1 x 10 M, a value of the sanie ofder
.. , .  , ' ,
of magnitude as the Km for the oxidative metabolism of CCl^F (3*2 x 10
This value is of the order frequently observed for microsomal 
mixed function oxidase substrates, and suggests that the oxidative 
metabolism of CCl^F occurs at the same site for the: metabolism 
of foreign compounds. The active sites for the aerobic metabolism 
of CCl^F must therefore be in close proximity to the activated oxygen 
molecule (Fig. 1.1.) and therefore be in close proximity of the haem 
iron of cytochrome P-U50.
The formation of the spectral intermediate absorbing at k ^ 2 nm 
under anaerobic conditions is thought to represent an interaction 
of an active intermediate with the haem iron of cytochrome P-^O and 
suggests that the site responsible for the formation of this intermediate, 
and therefore that responsible for the formation of CHCl^F, may also 
be in close proximity to the haem iron.
There are large differences in both the Km and Vm a x values for 
aerobic and anaerobic metabolism. The site of aerobic metabolism showed 
a higher affinity for CCl^F and the process had a higher \ a x value.
This suggests that the oxidative metabolism of CCl^F occurs 
preferentially to anaerobic metabolism. If only one site is responsible 
for the metabolism of CCl^F these differences could be explained by 
the presence of two possible conformations of the active site, u n d e r  aerobic 
and anaerobic conditions respectively, i0e. the under aerobic conditions 
the enzyme site has a more favourable conformation for metabolism.
The finding that active metabolites of CCl^F bind irreversibly 
to rabbit liver microsomal proteins and lipids in vitro under both 
aerobic and anaerobic conditions is evidence for both aerobic and
anaerobic metabolism of CCl^F. The active intermediates could 
be any of those shown in Fig. 6.1. The initial rate of irreversible 
binding to liver microsomal proteins and lipids under anaerobic 
conditions was similar to the initial rate of formation of CHCl^F 
suggesting that irreversible binding is also mediated by the 
same activation process.
The formation of the CCl^F-reduced cytochrome P-i+ 50 complex 
with an absorption peak at nm represents a different interaction 
to the irreversible binding of CCl^F to microsomal proteins, as the 
cytochrome P - k 50 complex is immediately removed in the presence of 
oxygen, whereas irreversible binding remains unaffected.
All interactions exhibited under anaerobic conditions were inhibited 
markedly by carbon monoxide, and CHCl^F formation and irreversible 
binding were inhibited by metyrapone. It was not possible to determine 
the effect of metyrapone on the formation of the CCl^F-cytochrome 
P-lj-50 complex because of the interference of its own spectrum.
However these results are a further indication that these reactions 
result from the same activation process.
The oxidative metabolism of GCl^F was inhibited by carbon monoxide 
and metyrapone. No evidence has been obtained in this work which 
indicates that the flavoprotein, NADPH-cytochrome c reductase, is the 
active site of CCl^F metabolism, as has been reported by Slater & .
Sawyer (1971b) for CCl^.
6.3. Potential toxicity of CCl^F
As discussed in 1.2. there are no reports of CCl^F-induced 
hepatotoxicity in laboratory animals after either inhalation or 
oral dosing. The possibility of ;CC1F .toxicity must therefore be 
considered -with respect to long-term exposure, both alone and in 
conjunction with other compounds. The second possibility has already 
been discussed in 1.2.
Atoxic effect often associated with long-term exposure is 
that of chemical carcinogenicity. The normal household use of aerosol : 
sprays means that the majority of the population is continuously 
exposed to low concentrations of CCl^F. The work in this thesis has 
shown that metabolites of CCl^F bind irreversibly to microsomal 
proteins and lipids. The possibility that these metabolites may also 
bind to nucleic acids, and induce carcinogenesis cannot be discounted. 
The suggestion that halothane-induced liver necrosis, resulting from 
a second dose of this compound, is initiated by the binding of 
active metabolites to liver proteins (liehleke et^  al*, 1973b) suggests 
the possibility that a similar toxic effect may also occur with CCl^F.
The relevance of the potential toxicity of CCl^F must be brought 
into perspective in view of the reports that the accumulation of aerosol 
sprays into the upper atmosphere results in the degradation of 
atmospheric ozone. If this effect is established it seems likely that 
the use of chlorofluoroalkanes in aerosol sprays will be banned in 
the near future.
6 ,b, The contribution of this work to theories of halogenated hydrocarbon 
hepatotoxicity
The absence of CCl^F-induced hepatotoxicity make this a useful 
model compound for gaining insight into the mechanisms of halogeno- 
hydrocarbon toxicity. Throughout this thesis the results obtained 'with 
CCl^F have been compared with those obtained for the hepatotoxic 
compound CCl^. The many similarities in the physical properties of 
these compounds (see Fig. 1.^.) make the large difference in their 
toxicities an intriguing problem. Two possible explanations accounting 
for this difference have already been discussed in 1.6. The work 
described in this thesis indicates that these theories are too 
simple to provide a full explanation for this phenomenon. The concept 
that CCl^Fj in comparison with CC1^9 is biologically stable is not 
valid for the following reasons:
1) The oxidative metabolism of CCl^ and CCl^F in vitro occurs 
at the same rate and both compounds shown a similar affinity for the 
enzyme involved. Km values, derived from the substrate-induced 
rate of oxygen uptake in rat liver microsomal preparations, of
3.5 x 10 M and 3.8 x 10 ^ and V values of 11.2 and 11.6 nmole/min/instx
mg protein were obtained for CCl^F and CCl^ respectively.
2) Under anaerobic conditions more reduced metabolite was produced 
in the case of CCl^, however the magnitude of the complex formed with 
reduced cytochrome P-I450 was much larger in the case of CCl^F.
3) Under anaerobic conditions, the irreversible binding of CCl^ 
to microsomal proteins and lipids in vitro was twice that measured 
for CCl^F. However, under aerobic conditions, which must be assumed 
closer to the in vivo situation, more CC1_F was found bound to  — —  > 3
microsomal proteins than in the case of CCl^.
U) CCl^F has heen shown to be metabolised in rats in vivo, 
approximately 10% of the dose being excreted as carbon dioxide and 
as non-volatile metabolites in the urine and faeces. This value 
is much higher than,the majority of reports on the in vivo metabolism 
of CCl^, but direct comparison of the results for CCl^F with literature 
values for CCl^ is not possible because of variables such as, animal 
species, route of administration, and size of dose.
There is therefore considerable evidence that metabolism of 
CCl^F occurs both in vitro and in vivo, and to a comparable extent 
to that of CCl^. In NADPH-fortified liver microsomal preparations 
CCl^F shows nearly all the interactions exhibited by CCl^. The 
most marked difference between these two compounds is the induction 
of microsomal lipid peroxidation. It has been suggested that the 
irreversible binding of CCl^ metabolites to liver lipids is the 
initiating step in CCl^-induced lipid peroxidation. The amount 
of CCl^F that binds to liver microsomal macromolecules under aerobic 
conditions is similar to the binding exhibited by CCl^, yet in 
comparison with CCl^ CCl^F does not induce significant levels of 
lipid peroxidation. The mechanism of CCl^-induced lipid peroxidation 
suggested by Kao 8c Recknagel (1969) does not involve the direct 
binding of active metabolites to lipid molecules and postulates 
the abstraction of a hydrogen atom from a a-methylene group in 
unsaturated lipids. Nevertheless it is difficult to conceive of a 
mechanism involving radicals where both reactions would not occur 
simultaneously. If the mechanism of CCl^-induced lipid peroxidation 
is due to the interaction of free radicals with unsaturated lipids, 
then the active intermediates producing irreversible binding of CCl^F
are unlikely to be free radicals or CC1F-would be expected to 
initiate similar reactions. There is considerable evidence that the 
toxicity of CCl^ is mediated by the formation of active metabolic 
intermediates and many workers have suggested that CCl^-induced lipid 
peroxidation is the initiating step in CCl^-induced liver necrosis 
(see Recknagel et al., 197*0 • However no direct evidence has been 
reported showing that this is the case. The basis of this theory 
is that lipid peroxidation correlates with, the irreversible binding 
of CCl^ to microsomal lipids (Rao & Recknagel, 1969)5 the degradation 
of liver enzymes such as cytochrome P-t50 (Reiner et al., 1972), and 
the onset of hepatic necrosis,,(Recknagel et al. 197*+). There is 
no doubt that lipid peroxidation accellerates cell necrosis but 
whether this is the initiating event or even plays a major role in 
cell necrosis remains unproven. Indeed Toranzo et al. (1975) have 
suggested that the CCl^-mediated degradation of cytochrome P-*+50 
in vivo is not mediated by lipid peroxidation but results from the 
direct interaction of cytochrome P-I15O with the active metabolite. 
Another major argument against the lipid peroxidation theory is that 
the analogous compound, chloroform, is known to cause hepatic necrosis 
but does not cause lipid peroxidation (Slater, 1972). It is also 
worthy of note that less chloroform is bound irreversibly to microsomal 
proteins and lipids under aerobic or anaerobic conditions than CCl^F 
(Table 5.3.). If binding represents the initiating step in
chloroform-induced liver necrosis, as suggested by I lett et al.(l973) 
either the intermediates are different from those involved in CCl^F 
binding, or the experimental conditions 111 vitro are not representative 
of the situation in vivo. It must be mentioned that covalent binding 
does not necessarily indicate that a compound is toxic; this depends 
largely on the nature of the target molecules (see Gillette 197*0.
The in vivo experiments carried out here have shown that an 
oral dose of CCl^F in rats has a biological half-life of k , 5 h and 
that 95% of the dose is excreted within 2k h. This indicates that 
the liver must be exposed to CCl^F for several hours. Although 
the biological half-life of-CCl^ is probably longer, reports indicate 
that 70 - 80% of the dose is excreted within 2k h which is similar 
to CCl^F. This suggests that exposure of the liver to CCl^ is 
not inordinately longer. Cox (1972) reported that no signs of 
CCl^F-induced hepatotoxicity were apparent in rats receiving 
^00 mg/kg per day for 37 days. In conjunction with the experiments 
reported here this implies that the lack of toxicity due to CCl^F 
is probably not a factor of the concentration which reaches the liver. 
This argument is also supported by the reported rapidity of CCl^-induced 
liver damage which occurs within the first 5 - 15 niin after oral 
dosing (Rao & Recknagel, 1969).
The difference in the toxicities of CCl^F and CCl^ could be 
explained by one of the following;
1) The concentration of active metabolic intermediate’derived 
from CCl^ is much greater than that derived from CCl^F. In this 
event it is possible that endogenous trapping agents such as 
glutathione and vitamin E, are present in sufficiently high 
concentration to control active intermediates from CCl^F but are not 
present in high enough concentration to prevent CCl^-induced liver 
damage. If lipid peroxidation is the initiating step in cell 
necrosis this theory will not explain why CCl^F does not give rise 
to lipid peroxidation in vitro in the absence of such trapping 
reagents.
2) The active metabolic intermediates derived from CCl^F and 
CCl^ may have different stabilities. If these intermediates are less 
stable in the case of CCl^F, they would tend to cause more localised 
damage. A wide distribution of CCl^ intermediates would be expected 
to cause more damage to cell constituents. However at present there 
is no histopathological evidence of any CCl^F induced liver damage.
3) A type of active intermediate is produced by metabolism of 
CCl^ which is not produced during the metabolism of CCl^F. It would 
seem unlikely that metabolism of these two compounds at the same site 
would give rise to different intermediates. This would suggest that 
CCl^ is metabolised at a second site other than cytochrome P-h50.
This is in agreement with one of the theories proposed in 1.5. The 
second site may be the flavoprotein NADPH-cytochrome c reductase as 
suggested by Slater (1971b). It could be metabolism at this site which 
gives rise to toxic intermediates.
This work provides evidence that the "third ■ possibility will 
best explain the difference in the toxicity between CGl^F and CCl^. 
However all three possibilities may be contributing factors. It is 
generally accepted that the active intermediate which induces CCl^ 
toxicity is a free radical, which would imply that the intermediates 
in'the metabolism of CCl^F and CCl^ which give reduced metabolites 
and COg, via cytochrome P-k ^O, are not free radicals.
The majority of experiments described in this thesis were carried 
ou't in vitro although some of the findings were confirmed in vivo.
The true nature of the active intermediates involved in CCl^F 
metabolism, and whether these intermediates differ from those produced 
during the metabolism of CCl^ remain to be determined.
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Appendix
1. Concentration of the metabolite of CCl^F from anaerobic rat liver 
microsomal incubations
In order to obtain sufficient metabolite for mass spectral analysis 
incubations of CCl^F with rat liver 15.000 g supernatant fractions were 
carried out, as described in 2.2.6, for *+0 min. Each incubate was 
extracted with n-heptane (10 ml) and centrifuged in a screw-capped tube 
at 2000 r .p.m. for lh (MSE Mistral 6i-). The organic layer from nine 
incubations were pooled and a sample analysed by g-l.c. (see 2.2.7.) to 
determine the concentration of metabolite. The n-heptane extract was 
distilled for 3 h at room temperature, using the apparatus shown in 
Fig. 1., with occasional heating of the distillation flask with warm water. 
Following this the graduated tube was partially disconnected and 3 ml 
of n-heptane distilled'over. The distillate and the residual n-heptane 
extract were assayed by g-l.c. for metabolite. The distillate was 
stored at -20° before mass spectral analysis.
Using this technique it was possible to increase the concentration 
of metabolite from 5 x 10  ^g/g solvent in the extract to 1 x 10  ^g/g 
n-heptane in the distillate. After distillation no metabolite could be 
detected in the bulk n-heptane solution.
2. Determination of the efficiency of extraction of CC1J? and CHCl^F 
from microsomal preparations
The efficiency of extraction of CCl^F and CHCl^F from the incubation 
medium in experiments described in 2.2.6. was determined by adding CCl^F 
(10 mM) and CHClgF (0.05 mM) to tissue samples (protein cone11 8 mg/ml) 
suspended in 0.1 M tris-HCl buffer pH 7**4, at *4°. The mixture was shaken
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vigorously and then extracted with n-heptane (5 ml). The CCl^F and 
CHCl^F content in the n-heptane extracts was determined by g-l.c.
(see 2.2.7*) and compared with the g-l.c. analysis of samples of 
CC13F (10 mM) and CHClgF (0.0 5 mM) added directly to n-heptane (5 ml). 
Figs. 2a and 2b show the results of the analysis. The corresponding 
peak areas of the two analyses compared favourably and showed that the 
extraction of both CCl^F and CHCl^F was approximately 100%.
3* Determination of the loss of CCl^F during incubations
The possible loss of CCl^F during the anaerobic incubation of 
CCl^F with rat liver microsomal fractions was determined by incubating 
anaerobic microsomal fractions for tO min with CCl^F (10 mM), as 
described in 2.2.6., in the absence of an NADPH generating system.
After incubation the sample was cooled in ice and extracted with 
n-heptane (5ml). A typical g-l.c. analysis of an n-heptane extract is 
shown in Fig. 2c. Comparison of the CCl^F peak are obtained in this 
experiment with that of the standard CCl^F solution (Fig. 2b) shows 
that no loss of CCl^F occurred during the incubation.
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